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Contact details  
For general enquiries about the PreFIT study please email: prefit@warwick.ac.uk. 
For enquiries or comments about the content of this manual or the multifactorial falls 
prevention intervention, please email: julie.bruce@warwick.ac.uk. For contact 
relating to reporting of serious adverse events, please refer to Chapter 12 for 
contact details and fax numbers. 
 
Your local research nurse is: ___________________________________ 
Contact number: _____________________________________________ 
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Glossary and definitions  
Angina  Chest pain caused by ischaemia to the heart muscle tissue 
(myocardium). 
Arrhythmia  An irregular heart beat, including bradycardia or tachycardia.  
Benzodiazepines  A class of drugs to treat anxiety, epilepsy, mania, sleeping 
difficulties and alcohol withdrawal. Side effects can cause 
drowsiness, unsteadiness and memory problems.  
Bradycardia Slow heart rate, usually defined as <60 beats per minute although 
symptoms often do not occur unless heart rate <50 bpm. Context 
should be considered as fit, athletic adults have a slower heart rate.   
Carotid sinus 
syncope 
Fainting (syncope) caused by over-stimulation or over-activity of the 
carotid sinus, a receptor located in the carotid arteries of the neck. 
This can occur from wearing a tight collar, turning the head or 
looking up.  
Carotid sinus 
massage 
A process whereby the carotid sinus receptors, located in the 
arteries of the neck, can be stimulated manually to assess for 
hypersensitivity. Manual stimulation may cause changes in heart 
rate, blood pressure and can lead to temporary loss of 
consciousness (syncope).   
Cluster RCT A cluster trial is where a group of participants are randomisation to 
receive the same intervention together e.g. the cluster can be the 
general practice or a hospital rather than an individual person.  
PreFIT randomises a general practice to deliver either an 
intervention or control because this is easier to deliver and prevents 
‘contamination’.  
Contamination The inadvertent treatment with the intervention when someone is in 
the control group, or vice versa. Thus any unintended impact of the 
intervention on an individual in the control group, as might happen if 
a GP alters their ‘usual care’ applied to a control group participant 
(if they have recently treated another patient in the active 
intervention group).   
Hence the use of the cluster trial design which reduces the risk of 
this, as the practitioner is exposed only to control or intervention, 
not a mixture of both.   
Dizziness or 
giddiness 
Defined as feeling dizzy or giddy, light-headed, feeling as if going to 
faint. See vertigo.  
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Falls history 
 
Asking a participant about their history of falling. Involves taking a 
clinical history, exploring using a qualitative approach, about the 
factors that led to the fall. This includes context of fall, such as 
place and activity at the time.   
Integrated falls 
service 
Falls service working within a defined casemix of patients and 
working to agreed protocols and pathways. 
Medication review 
(DH definition) 
Structured review of the efficacy and continuing appropriateness of 
a patient’s medication.  
Medication review 
(ProFaNE 
definition) 
Comprehensive medication review to identify, resolve, and prevent 
medication-related problems, including adverse drug events with a 
special focus on medications associated with an increased fall risk 
e.g. antipsychotics, sedatives, hypnotics, antidepressants, 
antiarrhythmics, anti-convulsants, anxiolytics, antihypertensives and 
diuretics. 
Multi-agency 
service 
A service that involves different agencies e.g. health, social 
services and/or voluntary sector.  
Multi-factorial falls 
risk assessment  
An assessment of different risk factors for falling. For the purposes 
of PreFit, this includes assessment of: falls history, red flags, gait 
and balance, medication review, postural hypotension, vision, feet/ 
footwear and environmental factors.   
Multi-professional 
service 
e.g. medical, nursing, physiotherapy, occupational therapy, social 
work.  
Otago Exercise 
Programme 
A progressive, individualised strength and balance retraining 
programme developed and tested in New Zealand. It has been 
shown to prevent falls in older adults.  
OTC Over the counter non-prescription medications purchased from 
pharmacies and other outlets. 
Palpitations An abnormality of heartbeat that results in an awareness of the 
heart thumping in the chest (can be regular, irregular, fast or slow).  
Peripheral fracture This is the primary outcome for the study, defined as ‘any non-
spinal, non-pelvic fracture.’ This definition is based on work 
conducted by the ProFaNE research group.  
Polypharmacy Four or more medications being on a patient’s medication list – 
either prescribed or over the counter drugs. This may not 
necessarily be harmful and may indeed by necessary. However, 
polypharmacy is a risk factor for potential harm from medication. 
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Postural 
hypotension 
 
A sustained reduction of systolic blood pressure of at least 
20mmHg systolic (or below 100mmHg) or diastolic blood pressure 
of 10mmHg within 3 minutes of standing after having been lying 
down.  
Pragmatic study A study (usually a trial) that is designed to reflect how the 
intervention works within the real life situation e.g. within the usual 
healthcare setting.  
ProFaNE  
 
Prevention of Falls Network Europe – European Commission 
funded collaboration to reduce the burden of fall injury in older 
people through excellence in research and promotion of best 
practice.  
Proprioception The (unconscious) perception of movement and spatial orientation. 
Awareness or sense of position, location and orientation of the 
body. 
Psychotropic 
medication 
Any drugs used to treat psychoses and related disorders; also 
includes antidepressant drugs. 
Random allocation A method that uses the play of chance to assign participants to 
different groups in a trial. For PreFIT, general practices will be 
randomly allocated to deliver advice, exercise or MFFP. The 
randomisation procedure is done using a computer-generated 
random sequence (with a stratification variable added).  
Randomised 
Controlled  
Trial (RCT) 
An experiment where 2 or more interventions are tested against a 
control or comparison group, using random allocation.  
Red flags Term used to denote a sign or symptom that requires appropriate 
action e.g. such as referral to another health care specialist. 
Example may include bradycardia with syncope.  
Snellen Chart A contrast chart used to test visual acuity.  
Syncope Syncope refers to a temporary or transient loss of consciousness 
(fainting) with spontaneous recovery. This can be caused by loss of 
blood flow to the brain. 
Tachycardia A fast heartbeat, usually defined as >100bpm.  
Vertigo A sensation of spinning.  
Visual acuity Acuteness or sharpness of vision. 
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CHAPTER 1 
Introduction to Manual  
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1. INTRODUCTION TO MFFP MANUAL 
1.1 Introduction  
This is the multifactorial falls prevention (MFFP) manual for the Prevention of Fall 
Injury Trial (PreFIT). This manual has been written and designed for health 
professionals involved in the delivery of falls prevention services to older persons 
participating in the PreFIT study. Some healthcare professionals will have 
considerable experience of working in falls services prevention and will be very 
familiar with the rationale for falls prevention, assessment procedures, definitions 
and recommended treatment pathways. However, not all those working from this 
manual will have the same level of background training and experience therefore the 
manual has been developed to account for differing levels of skill, training and 
clinical expertise.  
 
The aims of this MFFP manual are: 
  To provide the scientific research evidence about the components within MFFP 
programmes and to describe the model selected for use in the Pre-FIT study;  
 To explain the rationale for the chosen study design; 
 To describe procedures for the assessment and treatment of trial participants 
who have been referred to MFFP services;  
 To describe trial documentation and adverse event reporting procedures.  
 
There are different sections to the manual:  
 Chapter 2 provides an overview of scientific evidence for falls prevention 
programmes. 
 Chapter 3 describes the rationale, aim and design of the PreFIT study.   
 Chapter 4 provides an overview of the PreFIT MFFP intervention, including the 
risk factors, recommended treatment pathways and how this relates to current 
UK national guidance.  
 Chapters 5 to 11 provide background information for each risk factor separately. 
A full description of “how to” assess each risk factor is given with recommended 
treatment pathways for when a risk factor is identified.  At the end of the risk 
factor chapters, examples of 3 case studies are provided.  
 Chapter 13 describes trial reporting procedures and related documentation, 
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including processes for reporting adverse events within the trial. 
1.2 Usual care vs PreFIT care  
This study manual will be given to primary and secondary care teams responsible for 
the assessment and treatment of older adults participating in PreFIT. We recognise 
that the content and procedures contained within this risk assessment manual may 
differ from the care usually delivered by your service e.g. there may be differences in 
the risk factors contained within the manual or in the recommended treatment 
pathways. This is to be expected and we acknowledge there is considerable 
variation in both type and delivery of falls services across the UK. However, for the 
purposes of a clinical trial, it is crucial that all healthcare providers use the same 
processes to assess risk of falling and adhere to the same treatment pathway if a 
risk factor has been identified. Therefore this manual has been produced to 
‘standardise’ the study MFFP intervention, to reduce the risk of differences arising 
between different care centres and providers.  Therefore, for all PreFIT trial 
participants referred to your service, we ask that you adhere to the content of this 
manual when assessing risk of falls. This should not affect your usual care of other 
non-trial patients referred to your service. You may decide to use some of the 
approaches within the manual for non-trial participants if you so wish.   
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1.3 The PreFIT Study Research Team  
 
 
 
 
 
Professor Sallie Lamb    Dr Julie Bruce  
Chief Investigator      PreFIT Research Lead 
Warwick Clinical Trials Unit   Warwick Clinical Trials Unit  
        
 
 
 
 
 
 
 
Mrs Emma Withers     Ms Susanne Finnegan 
Clinical Trial Co-ordinator    Research Fellow  
Tel. 02476 174656     Email: s.k.finnegan@warwick.ac.uk  
Email: prefit@warwick.ac.uk     
 
Professor Lamb is Director of the Warwick Clinical Trials Unit and is the Chief 
Investigator who has overall responsibility for the PreFIT study. Dr Julie Bruce is the 
research lead, also responsible for co-ordination and delivery of trial interventions. 
Julie is the first point of contact for any queries about the multifactorial falls 
prevention intervention, manual and related materials. As Trial Co-ordinator, Emma 
Withers is the administrative manager and has responsibility for day to day 
management and delivery of the trial. Ms Susanne Finnegan is a research 
physiotherapist with overall responsibility for the exercise intervention. Mr Rhys Mant 
(not pictured) is the Trial Administrator.   
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Other key PreFIT study team members include: 
 
 Mr Duncan Baird, Data Input Clerk, Warwick Clinical Trials Unit 
 Dr Sandra Eldridge, Professor of Biostatistics, Barts & London School of 
Medicine & Dentistry 
 Dr Tim Friede, Associate Professor in Medical Statistics, Warwick Medical 
School 
 Mrs Susie Hennings, Project Manager, Warwick Clinical Trials Unit  
 Dr Claire Hulme, Senior Lecturer in Health Economics, Leeds Institute of 
Health Sciences  
 Dr Ranjit Lall, Senior Research Fellow, Trial Statistician 
 Dr Roberta Longo, Research Fellow in Health Economics, Leeds Institute of 
Health Sciences 
 Mr Rhys Mant, Trial Administrator, Warwick Clinical Trials Unit  
 Dr Finbarr Martin, Consultant in Elderly Care Medicine, Kings College London  
 Dr Rachel Potter, PreFIT Research Nurse, Warwick Clinical Trials Unit  
 Dr Ray Sheridan, Consultant in Elderly Medicine, Royal Devon and Exeter 
Hospital (Clinical Champion, Devon Region)  
 Dr Dawn Skelton, Reader in Ageing and Health, Glasgow Caledonian 
University  
 Dr Anne-Marie Slowther, Associate Clinical Professor in Clinical Ethics, 
Warwick Clinical Trials Unit  
 Professor Martin Underwood, Professor of Primary Care Research, Warwick 
Clinical Trials Unit  
 Mrs Isabel Wall, Trial Administrator, Warwick Clinical Trials Unit  
 Professor Keith Willett, Professor of Orthopedic Trauma Surgery, University of 
Oxford (National Clinical Director for Trauma Care)  
 Professor Lucy Yardley, Professor of Health Psychology, University of 
Southampton  
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Copyright Statement  
This intervention manual was developed by the PreFIT Intervention Study Group 
coordinated by Dr Julie Bruce at the Warwick Clinical Trials Unit. The material for the 
PreFIT trial within should not be used, copied, stored or transmitted outside other 
than for the purposes of the clinical trial, without the prior written consent of the 
University of Warwick and in accordance with the Copyright, Designs and Patents 
Act 1988. Materials will be available on completion of the PreFIT trial, subject to 
approval by the Warwick Clinical Trials Unit Standard Operating Procedures on Data 
Management and Sharing.  
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CHAPTER 2 
Background to Falls Prevention Programmes 
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2. EVIDENCE FOR FALLS PREVENTION PROGRAMMES 
2.1  Early strategies to prevent falls  
Falls are a common problem among older adults with approximately 30% of those 
aged over 65 years, living in the community, falling each year. Although less than 1 
in 10 adults who fall sustain a fracture, many fall incidents require medical attention 
(Gillespie et al, 2003). Falls can result in pain from injuries, long-term disability and 
also mortality. Early reports of identifying risk factors for falling emerged from the 
USA in the late-1980s. This work, which focused on strategies to identify and reduce 
multiple risk factors, now termed multi-factorial fall prevention (MFFP), was 
conducted in Connecticut and funded by the National Institute on Aging (Tinetti et al, 
1994). The central theme of this research agenda was that falls and immobility do 
not result from increasing age alone, but from the accumulated effect of multiple 
impairments and disabilities (Tinetti et al, 1994; Koch, 1994). As such, many of these 
impairments are modifiable, suggesting that falls and immobility can be reduced. The 
‘Tinetti multifactorial fall programme’, tested within early explanatory trials, 
although small, were promising – results suggested that treatment of common health 
problems and hazards in older people decreased falling by more than 30% (Tinetti et 
al, 1994; Close et al, 1999).  
2.2   Fall prevention programmes:  the UK setting  
Evidence from the early multifactorial falls prevention programmes provided the 
foundation for the National Service Framework for Older People to mandate the NHS 
to establish MFFP programmes for people with a history of a fall (i.e. secondary 
prevention), and subsequently, for NICE to endorse this recommendation (NICE, 
2004). Consequently, many specialist falls prevention services were established 
throughout the UK, although this process was disparate, with variation in service 
development and models of delivery across different settings. An appraisal of fallers’ 
clinics was launched by NICE in 2004 but was subsequently suspended because of 
lack of information regarding existing services and their typology.   
2.3   UK Audit of falls services  
In 2007, a National Scoping Audit was launched to evaluate Faller’s Clinics in the UK 
(Lamb et al, 2007). This national audit revealed that most MFFP services in the UK 
consisted of multidisciplinary teams (92%) although these ranged widely by both size 
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and discipline represented. Of the 231 MFFP services responding to the national 
audit exercise, multifactorial assessment was conducted by almost all services 
(99%) and this consisted of: gait and balance assessment (91%), environment 
assessment (76%), medication review (72%), cardiovascular (69%) and, to a lesser 
extent, vision assessment (58%). Assessments of feet, bone health and hearing 
were conducted less frequently (<50% of services) although some clinics did involve 
podiatrists and, for example, specialist dietetic staff. Of those surveyed, 83% of 
MFFP clinics matched interventions to the findings of assessments: common 
interventions included information provision (94%), exercise interventions (89%) and 
medication reviews (66%) (Lamb et al, 2007).  
2.4  Systematic reviews of fall prevention programmes  
There are now over 100 published trials investigating the efficacy of fall prevention 
initiatives, but many of these studies have small sample sizes and are of low 
methodological quality. In 2003, a Cochrane systematic review included only four 
good quality trials investigating the effectiveness of multidisciplinary, multifactorial, 
health/environmental risk factor screening and intervention programmes: these trials 
suggested a 27% reduction in falls for unselected older populations in the community 
(Gillespie et al, 2003). For older adults with a history of falling or who were selected 
because of known risk factors, a 14% reduction in risk of falling was observed across 
five trials. There was insufficient evidence to know whether MFFP programmes 
prevented fall-related injuries. One of the drivers for preventing falls is to prevent 
factures and injuries - falls cause fractures which lead to hospital admission and are 
associated with disability and loss of independence. Fractures are costly to treat and 
require substantial amounts of care.  
2.5 Recent trials of MFFP interventions  
Since publication of the original MFFP studies and the Cochrane systematic review, 
there have been several other well-conducted, large trials in the UK and Netherlands 
investigating the effectiveness of MFFP. These studies, somewhat surprisingly, 
found no evidence of fall or fracture reduction (Lord et al, 2005). Additionally, 
recently updated high quality systematic reviews concluded that MFFP might be 
substantially less effective than previously thought and possibly not effective at all 
(Gates et al, 2008; Gillespie et al, 2003); (Gillespie et al, 2009), updated Cochrane 
review). This means that there is a possibility that tax-payers money is being 
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directed towards strategies that are not effective and this money could be reinvested 
towards more effective strategies for falls and fracture prevention in older people in 
the community.  
2.6 Is exercise effective in preventing falls in older adults?  
There have been other trials investigating the benefits of exercise in preventing falls 
among older adults living in the community. Exercise, specifically training in strength, 
balance and flexibility, has been shown to be effective in reducing falling in older 
adults. People, even aged in their 90s, can improve their strength and balance to 
achieve stability and avoid falls. Our best estimate is that exercise reduces falls by 
about 25%, although this is dependent upon the casemix and upon the mode and 
intensity of exercise (Gillespie et al, 2009).  There are some difficulties with exercise, 
in particular, with ensuring that people take enough exercise, and that they adhere to 
it in the longer term. 
2.7 Is exercise more effective than MFFP?  
At present, we do not know how exercise and MFFP programmes compare because 
there have been no studies directly comparing one against the other. There have 
been no studies directly comparing MFFP programmes to exercise only to 
investigate whether there is any added benefit from a more comprehensive 
programme. It is also crucial to consider the impact of programmes in preventing 
falls-related injury (fractures) in older adults. It may be that the exercise component 
within MFFP programmes contributes most to the reduction in falls and fractures. If 
so, this is important because exercise may be a safer, cheaper and more acceptable 
option for delivering services to older patients. Furthermore, adherence to exercise 
to achieve the necessary ‘dose’ might be adversely affected by simultaneous 
participation in other interventions.  
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CHAPTER 2.  Key Points  
 
 Early studies of MFFP programmes reported a 30% reduction in falls 
in older adults.  
 
 More recent studies found that MFFP programmes are substantially 
less effective than previously thought. 
  
 Exercise, particularly strength and balance training, is effective in 
reducing falls in older adults.  
 
 No large, well-conducted study has directly compared exercise with 
MFFP in preventing falls and fractures in older people living in the 
community.  
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CHAPTER 3 
The PreFIT Study 
Aims, Objectives & Trial Design 
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3. AIMS OF PREFIT STUDY  
3.1  Rationale for PreFIT  
Given the background of clinical uncertainty described in Chapter 1, there is a need 
to conduct a large, well-designed study to compare different strategies for preventing 
falls and fractures among older adults living in the community. The Prevention of Fall 
Injury Trial (PreFIT) has been designed for this purpose. It is a multi-centre, 3-arm, 
cluster-randomised, controlled trial, with economic analysis. The trial will evaluate 
the clinical and cost-effectiveness of three primary care fall prevention interventions: 
(1) advice alone, (2) advice supplemented with exercise and (3) advice 
supplemented with MFFP. These trial interventions – exercise and MFFP - are 
currently widely available in the UK, but little is known about their comparative 
effectiveness. The PreFIT trial therefore will provide evidence about which is the 
most effective and cost-effective service for reducing falls and fractures in 
community-dwelling older adults.  
3.2  Aim of PreFIT  
The primary objective of the trial is to establish the comparative effectiveness of 
three primary care fall prevention interventions (advice, and advice supplemented 
with either exercise or MFFP) for older people living in the community. The study 
aims to contribute evidence to inform UK healthcare practitioners, commissioners 
and other stakeholders on the relative effectiveness and cost-effectiveness of a 
range of primary care options for preventing falls and fractures. The PreFIT study is 
using peripheral fracture rates as the primary outcome, therefore a very large trial 
is required to detect a difference in peripheral fractures between groups. For the 
purposes of this study, peripheral are defined as any non-spinal or non-pelvic 
fracture. The PreFIT study will recruit 9000 older adults across different regions in 
England.   
 
The secondary objectives are to: 
 Measure the uptake of the active interventions (i.e. exercise and MFFP) and 
quantify observed differences; 
 Assess the relative effectiveness of interventions for the prevention of falls 
and peripheral fractures in people of different ages, gender and fall history; 
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 Assess the relative costs of each intervention and establish the most cost-
effective approach for preventing falls and fractures. 
These results should also enable us to estimate the population impact of the 
intervention in terms of peripheral fractures, taking into account the differential 
effectiveness and different fracture incidence in subgroups of the older population.  
3.3 Study design  
The PreFIT study is a pragmatic cluster randomised controlled trial (RCT), with the 
unit of randomisation being the general practice or ‘cluster’ rather than individual 
study participants (see Glossary). This cluster design has been selected to avoid 
contamination – it would be difficult for GPs to randomize individual patients to 
different treatment interventions in the same practice and to study uptake of different 
interventions. Hence a cluster design was chosen. A pragmatic study means that 
the trial has been designed to reflect the real life situation within the healthcare 
setting. Thus rather than examine Pre-FIT interventions under ideal or tightly 
controlled experimental conditions, the study will examine how these interventions 
are delivered within the pressures and constraints of the existing healthcare setting 
and environment.  Figure 1 displays a flowchart of recruitment processes for the trial.  
3.4 Does the trial have ethical approval?  
In the UK, all research involving data collected from NHS patients must be approved 
by a research ethics committee. The PreFIT study has full ethical approval from a 
multi-centre research ethics committee (MREC) with additional site specific approval 
from each participating region. Approval has also been obtained from R&D 
departments within NHS Healthcare/ Primary Care Trusts from participating regions.   
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Figure 1 - Trial Flow Diagram 
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3.5 Who is eligible to participate in the PreFIT study?  
The trial will recruit 9000 adults over the age of 70 years, who live in the community, 
either at home or in sheltered accommodation. Of those recruited and consented to 
participate, GPs will then screen for risk of falls using a simple postal questionnaire. 
PreFIT study participants will be referred for falls assessment based on responses to 
this self-screening survey. You will assess participants who are considered at 
intermediate or high risk of falling (Box 1) You are being asked to assess and treat 
older adults, who live in the community, who have identified themselves as being at 
risk of falling and are willing to undergo assessment and treatment. This patient 
group, therefore, may differ slightly from the ‘usual’ patient referred for falls risk. An 
additional objective of the study is to assess the uptake of services by those deemed 
at risk.  
assessment. 
 
 
 
3.6 Does the PreFIT study adhere to current national guidance on falls 
prevention?  
The National Institute for Clinical Excellence (NICE, 2004) has published 
recommendations for screening for risk of falls; this states that all older adults, 
defined as those aged over 65 years, should be screened and advised about risk of 
PreFIT Study Entry Criteria 
 Aged over 70 years; 
 Live in the community at home or in sheltered accommodation; 
 Person has life expectancy of >6 months; 
 GP considers eligible for inclusion in the trial; 
 Has consented to participate in study. 
Referral criteria:- 
 Person has fallen twice or more in the last year; or 
 Person has fallen once in the last year and has balance difficulty; or 
 Person has not fallen in the last year but they report balance difficulties or 
other difficulty with particular daily activities, such as dressing, bathing etc.; 
 Person not currently attending a falls service. 
 
Box 1 - PreFIT participants referred for MFFP assessment 
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falls when they come into contact with any healthcare provider. However, recent 
audits have shown that this is not always the case. One recent National Audit of 
Falls and Bone Health in older people (RCP, 2010) found that even when older 
people attend hospital with serious fall-related injuries (e.g. fracture), they are not 
being properly assessed in order to prevent further injuries. One key conclusion from 
this national audit was that “most primary care organisations lack adequate services 
for secondary falls and fracture prevention”. The PreFIT study does focus on primary 
rather than secondary prevention, thus aims to prevent falls and fractures rather than 
treat those who have already fallen. One third of PreFIT trial participants will receive 
an advice leaflet, as this is included in NICE guidance as a standard intervention 
(refer to AgeUK leaflet, Appendix 1). This advice leaflet may be more than is 
currently provided to older adults, given the pressures and demands on existing 
primary care services (Box 2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Box 2 - Advice on falls prevention 
Despite national guidance recommending that older adults should be screened and 
advised about risk of falls when they come into contact with any healthcare provider, 
national audits show this is rarely the case (NICE, 2001; NICE, 2004).  This is 
perhaps understanding, particularly when falls prevention is not currently part of the 
NHS Quality and Outcomes Framework (QOF) and given current multiple pressures 
on GP consultation time. 
 
An advantage of the PreFIT trial is that all participants will receive high quality 
general advice about falls prevention in the form of a comprehensive AgeUK leaflet.  
This advice leaflet is designed to encourage those who are fit and well to remain this 
way, and for those who are not, it provides “self-help” tips. 
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CHAPTER 3.  Key Points  
 
 The PreFIT study is an NHS Health Technology Assessment-funded 
research study which uses a multicentre, pragmatic, cluster, 
randomised controlled trial (RCT) design. 
 
 The trial is based in primary care and will a sample of community-
dwelling older adults aged over 70 years 
 
 The three interventions are advice only, advice plus exercise or 
advice plus MFFP on outcomes of peripheral fractures (primary 
outcome) and falls   
 
 The PreFIT study uses a primary-care screening approach (balance 
screener) to identify participants at risk of falling.  
 
 A subgroup of recruited participants will be offered MFFP assessment 
 
30 
 
31 
 
CHAPTER 4 
 
The PreFIT MFFP Intervention 
An Overview 
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4. THE PREFIT STUDY MFFP INTERVENTION  
 
4.1 The Tinetti Model of Falls Prevention  
The national UK survey of falls clinics identified various models of falls prevention 
services. For the purposes of the PreFIT study, the original multifactorial falls 
prevention programme from Connecticut (Tinetti et al, 1994) was selected as the 
MFFP model of choice. As stated in Chapter 2, this programme found that treatment 
of common health problems and hazards decreased falling by more than 30%. The 
Connecticut Collaboration for Fall Prevention, based at Yale University School of 
Medicine, encouraged local clinicians in the Connecticut area to incorporate fall risk 
assessment and treatment into their care of older adults. The common problems and 
hazards associated with falling included: difficulties with walking or moving around; 
multiple medications; tripping hazards; postural hypotension; visual problems; foot 
problems and unsafe footwear. The original USA 1994 protocol and exercise 
(physical) therapy component was developed using a consensus approach with 
experienced geriatricians, physical therapists, home-care and rehabilitation nurses. 
The core components of the original Tinetti model included assessment and 
treatment of different risk factors (Box 3).  This model was implemented in a 
subsequent trial, whereby practitioners adhered to assessment and treatment 
components (Tinetti et al, 1994).  
 
 
 
 
Box 3 - Risk factors included within the USA Model (Tinetti et al., 1994; 1995a; 
1995b) 
 Impairment of gait, transfers or balance; 
 Multiple (>4) medications  or ”culprit” medications; 
 Postural hypotension/dizziness; 
 Perception/sensory deficits: vision, hearing, feet (decreased position sense) 
 Foot (pain, numbness, bunion etc.) or footwear problems; 
 Environmental hazards. 
33 
 
4.2  Adaptations to the Tinetti Model for the PreFIT study  
The protocol and materials developed by the Connecticut research team are widely 
available to other clinicians and healthcare workers (Tinetti et al, 1988; Tinetti et al, 
1994). For the purposes of PreFIT, the original Tinetti programme has been modified 
for use in the UK healthcare setting. Adaptations have been made to update the 
original programme to comply with UK national recommendations and latest 
evidence e.g. NICE Clinical Practice Guideline (NICE, 2004); British Geriatrics 
Society (BGS)/American Geriatrics Society (AGS) 2010. The NICE 2004 guideline 
was developed from a series of in-depth, high quality systematic reviews of falls 
prevention and treatment literature. The PreFIT MFFP intervention therefore 
complies with latest research evidence and national evidence-based guidance.   
 
4.3 The need for standardisation  
As described in Chapter 3, there are different models of MFFP falls prevention 
services in the UK, e.g. community health falls services, secondary care-led 
services, and other models with appropriately trained healthcare professionals (e.g. 
primary care). We believe that the most feasible and generalisable model for PreFIT, 
given the large numbers involved, is primary care based services or local community 
multidisciplinary falls services. However, referral to a secondary care specialist 
service is also another possible and acceptable model of delivery.  
 
4.4 Components included within the PreFIT MFFP intervention  
The core components of the PreFIT MFFP intervention include assessment and 
treatment of seven risk factors (Box 4). The assessment of ‘red flags’ (see page 38) 
is integral within taking a falls history although it has been listed as a separate risk 
factor on the summary pictorial assessment sheet (Appendix 10). Risk assessment 
is linked to recommended treatment pathways however treatment or intervention is 
only required where a particular risk factor has been identified.  
 
4.5 Advice about foot care and footwear.  
Although NICE reviewed studies of feet/footwear/podiatry interventions, no specific 
guidance or advice relating to footwear or foot care was provided within clinical 
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practice statement. The AGS/BGS guidance graded evidence for inclusion of 
feet/footwear components within MFFP interventions as “C” [no recommendation for 
or against the routine provision of the intervention is made. At least fair evidence was 
found that the intervention can improve health outcomes, but the balance of benefit 
and harm is too close to justify a general recommendation]. However, the AGS/BGS 
do recommend that examination of the feet and footwear and appropriate treatment 
(unspecified) should be included within MFFP interventions. The PreFIT programme 
therefore has included assessment and treatment for foot problems (Chapter 9).   
 
Box 4 - Components within the PreFIT MFFP intervention 
Risk factors included within PreFIT 
intervention (NICE/AGS-BGS guidance) 
Excluded risk factors 
 Falls history & red flags X Hearing  
 Impairments of gait and balance X Osteoporosis  
 Postural hypotension X Cognitive impairment  
 Multiple or ‘culprit’ medications X Neurological examination 
 Vision  X Carotid sinus hypersensitivity 
 Foot problems  
 Environmental hazards  
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Box 5 - Summary of risk factors, assessment and treatment options 
Risk factor Assessment conducted 
by trained assessor1 
Recommended treatment pathway 
(if risk factor identified) 
History of 
falling 
Conduct detailed falls 
history. 
Check for red flags. 
Refer to appropriate service for further 
investigation if warranted. 
Gait and 
Balance 
Timed Up and Go Test. 
History of tripping 
/stumbling/loss of 
balance. Using furniture 
whilst walking.  
Refer to physiotherapy services for 
strength and balance retraining (Otago 
Home Exercise Programme). 
Postural 
Hypotension  
Pulse, lying/standing BP. Medication review. Refer to other 
services if cardiac disease suspected. 
Type of 
medication 
Review number, class of 
prescribed medications 
also use of OTC’s.2 
Check whether on 
psychotropics.  
Reduce or eliminate culprit 
medications, night sedation and anti-
psychotics.  
Vision Eye test history & Snellen 
test. 
Refer to optician for eye check. 
Refer to ophthalmology services if eye 
disease suspected.   
Foot problems Visual inspection of feet 
and footwear. 
Provide advice. If indicated, arrange 
referral to local NHS podiatry/chiropody 
services or recommend appointment at 
private services. 
Refer to Otago Home Exercise 
Programme if foot placement/balance 
compromised.  
Environmental 
hazards 
Screen for potential home 
hazards. 
Give advice leaflets. 
Arrange referral to occupational therapy 
for home assessment if indicated.  
                                               
1 Falls risk assessment can be conducted by nursing or other healthcare staff who have 
completed PreFIT training.   
2 Medication reviews may be conducted by non-medically trained staff but all changes must 
be checked, approved and signed by a medically trained practitioner. 
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4.6  Components not included in the PreFIT programme  
a) Hearing  
The original Tinetti MFFP model included checks for impaired hearing as a risk factor 
for falling. However, recent NICE and AGS/BGS guidance do not include 
recommendations for the assessment and treatment of hearing problems within 
MFFP programmes. Although trials have included assessment of hearing within 
multifactorial interventions, these trials have either been methodologically flawed or 
failed to demonstrate any reduction in falls (NICE, 2004). The PreFIT MFFP 
intervention, therefore, does not include assessment of hearing problems.  
b) Risk of osteoporosis  
Osteoporosis is loss of bone mass and destruction of bone tissue which causes 
weakening of the bones making them more likely to fracture. Postmenopausal 
women are most at risk of developing osteoporosis; other risk factors include 
increasing age, diet, lifestyle factors, chronic inflammatory diseases, diabetes and 
certain medications. There are different tools to estimate risk of fragility fracture both 
in individuals who have had a fracture and those who have not (e.g. FRAX risk 
assessment http://www.shef.ac.uk/FRAX). Certain drugs, such as the 
bisphosphonates e.g. alendronate, are recommended as treatment for preventing 
fractures in postmenopausal women who have had osteoporosis diagnosed but have 
not had a fracture (NICE, 2011). Guidelines on the prevention and treatment of 
osteoporosis and on the use of Vitamin D for fracture prevention are currently in 
development (and revision) by NICE. For the purpose of the PreFIT study, we have 
not included an assessment of risk of osteoporosis.  
c) Cognitive impairment and neurological examination  
Patients with severe cognitive impairment will be ineligible for inclusion, however it is 
possible that patients with mild cognitive impairment participate in the study. It is also 
very possible that for some participants, cognitive ability will decline during the 
course of study follow-up. The PreFIT MFFP intervention does not include detailed 
assessment of cognitive impairment or detailed neurological examination. The NICE 
guidance review found no evidence that cognitive/behavioural interventions alone 
reduce the incidence of falls in community-dwelling older people (NICE, 2004). There 
was also no evidence that complex behavioural interventions, such as group 
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activities (education, behaviour modification programmes) were effective in falls 
prevention in community-dwelling older people. The PreFIT study will assess 
cognitive function within baseline and follow-up data instruments.  
d) Carotid sinus hypersensitivity  
Cardiac pacing (insertion of a pacemaker) is effective in reducing falls and syncope 
in community-dwelling older adults with cardioinhibitory carotid sinus hypersensitivity 
who have experienced unexplained falls. NICE guidance does state that 
cardiovascular assessment should be carried out within a multifactorial assessment, 
where appropriate (NICE, 2004). This guidance is based on evidence from one trial 
which found a statistically significant reduction in falls and syncope after cardiac 
pacing for cardioinhibitory carotid sinus hypersensitivity in fallers who attended a 
hospital emergency department (Kenny, 1999).  The AGS/BGS guidance also states 
that dual chamber cardiac pacing should be considered for older persons with 
cardioinhibitory carotid sinus hypersensitivity who experience unexplained falls.  For 
the purpose of PreFIT, we ask assessors to check heart rate and screen for postural 
hypotension. For safety reasons, bearing in mind the different clinical backgrounds of 
practitioners conducting assessments (and possible barriers to accessing clinicians 
in community settings), we do not recommend that carotid artery stimulation be 
conducted to check for carotid sinus hypersensitivity. If a participant has experienced 
unexplained falls, these should be referred to a consultant-led falls or secondary 
care service for further assessment.  Unexplained recurrent falls might represent the 
effect of syncope or transient pre-syncopal disturbance to cerebral blood flow 
sufficient to induce a fall in an individual with other risk factors. In this instance, 
referral for consultant led assessment is recommended.  
4.7 The next chapter  
The next section of the manual describes each of the individual risk factors included 
within the PreFIT intervention: falls history with red flags, gait and balance, postural 
hypotension, vision, medication reviews, foot assessment and environmental 
modifications. Each chapter provides background details and relevant definitions for 
each of the included risk factors. A description of “how to” assess each risk factor 
and a recommended treatment pathway is provided. 
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CHAPTER 4.  Key Points  
 
 The PreFIT MFFP intervention is based on the Tinetti (1994) 
programme with modifications to comply with current UK national 
guidance on falls prevention.  
 
 The key components of the PreFIT MFFP intervention include: 
conducting a falls history/checking for red flags; assessment of gait 
and balance, postural hypotension, medication screen and review, 
vision, foot problems and consideration of the home environment.   
 
 The PreFIT MFFP intervention focuses on individualized assessment 
and targeted referral for further treatment or intervention if a risk 
factor is identified.  
 
 Most, but not all, of the PreFIT MFFP intervention can be conducted 
by a suitably trained, non-medical healthcare professional – however, 
this must be supplemented with onward referral and/or discussion 
with a suitably trained medical practitioner e.g. GP or consultant-led 
falls service if indicated.  
 
 A non-medically trained healthcare practitioner can complete falls 
assessment materials for PreFIT study participants. However, a 
medically trained practitioner must approve any changes to 
medication resulting from a medication review.  
 
 
  
39 
 
CHAPTER 5 
 
 
 
Risk assessment 
Falls history interview & red flags 
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Risk assessment: History of falling  
 
5.1 Conducting a falls history assessment  
The purpose of eliciting a falls history in an older person is to identify and explore 
any predisposing factors leading to a fall. It is important to explore the context and 
consequences of any previous falls – this could provide clues about causation. 
Eliciting a falls history involves good communication skills and systematic enquiry 
about fall-related events. When conducting the interview, provide clear explanations, 
free from jargon which the patient can understand. The interviewer should develop 
the skills to follow relevant leads in the conversation and use a good balance of 
open, exploratory and closed questions. The interview should be conducted at an 
appropriate pace without rushing the person and without inappropriate interruptions 
during their explanations of events.  
 
5.2 When taking the falls history  
It is important to get a clear story of one specific event, usually the most recent fall. 
Take the patient through the event from before, during and afterwards. The context 
may be quite mundane but still important to establish. A fall occurs in an individual 
with a specific mosaic of characteristics, (some of which might increase their falls 
risk), in a specific context such that their postural stability is overcome. The risk of 
falling has been shown to increase as the number of these risk factors increases. 
Any context can be described in terms of the “falls hazards” they contain. The 
magnitude of association of a fall with any intrinsic or environmental factor is not 
fixed, but is mutually interdependent and contingent on additional factors influencing 
performance of the specific activity in question. 
So the question is not only why the patient was prone to falling, but also why did the 
fall happen on that particular occasion? This approach leads to identifying intrinsic 
risk factors, relevant activities and environmental challenges, any of which may be 
amenable to modification.  
Another factor to explore during the interview is fear or worry about falling. Fear of 
falling is common in elderly people and is associated with poor balance, anxiety, 
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depression, and falls. These fears may be reasonable and suggest good awareness 
about actual falls risk, or fears may be exaggerated, suggesting the person might be 
overly anxious.   
5.2  Definition of a fall  
The recommended definition of a fall is “an unexpected event in which the participant 
comes to rest on the ground, floor or lower level.” (Lamb et al, 2005a). However, for 
the purposes of interviewing, the following lay definition of a fall should be used – “in 
the last year (or state timeframe), have you had any fall including a slip or trip in 
which you lost your balance and landed on the floor or ground or lower level?”  
These definitions were generated and agreed by the Prevention of Falls Network 
Europe (ProFaNE), a collaborative project funded by the European Commission 
(Lamb et al, 2005b).  Although the PreFIT study recommends asking about any falls 
in the last year, recall bias can be a problem. Research evidence suggests that older 
adults can recall falls in a general way over a 1-year period, but recall for the precise 
timing of events in the previous 3 to 6 months can be more problematic (Lamb et al, 
2005a).  
5.3   Red Flags  
Red flags are warning signs that referral to a GP or medical specialist 
may be warranted. For example, a participant with cardiac abnormalities, 
such as bradycardia and a history of near fainting or syncope will require referral to a 
local specialist service for falls/syncope assessment. Other examples that will 
require referral to specialist assessment include symptoms suggestive of seizure 
activity such as visual aura and tongue biting.  
 
Taking a good falls history is an important skill which can be honed over time. There 
is no single question or validated algorithm to follow when elucidating an accurate 
falls history – it requires good listing skills and also the ability to link different risk 
factors to each other e.g. visual problems may relate to tripping with the home or 
outdoors; dizziness on standing may be related to particular psychotropic 
medications etc. Refer to the example case studies provided at the end of this 
section of the manual. 
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RISK FACTOR ASSESSMENT  a) Taking a Falls History  
 
Conducting the falls history interview 
Introduce yourself and explain the purpose of the appointment. Screen for falls by 
using the falls history screening questions in Box 6 below. For non-fallers with 
balance difficulties, explore circumstances and context further by asking about types 
of balance difficulties. For example, enquire about dizziness, weakness in the legs, 
any palpitations or visual disturbances (see Table 1 below). For those participants 
who have fallen before, conduct a full falls history and explore the factors using the 
questions listed in the Box 6 below.  
 
 
 
Table 1 - Questions to use during a falls history interview 
Question Possible / probable cause of falls & onward 
treatment pathway  
Any dizziness or 
giddiness? 
Dizziness or giddiness defined as feeling dizzy or light-
headed, as if going to faint. Ask about circumstances. 
Check for postural hypotension (Chapter 7).   
Any vertigo? A sensation of spinning. May represent vestibular 
disease which requires medical diagnosis.  
Any muscle weakness 
in the legs? Is one leg 
weaker than the other? 
If the person has one leg weaker than the other, this 
requires a full medical review. Refer to consultant-led 
falls service or secondary care. 
Any sudden loss of 
consciousness? 
Any sudden, unexplained loss of consciousness 
(syncope) requires a medical review. Reasons may 
include anything from a vasovagal faint to a cardiac 
arrhythmia or other cardiac problem.  Requires referral 
Q1. Have you fallen in the last 12 months? 
If yes or no, continue to Q2. 
Q2. Do you have any difficulties with your balance whilst walking or 
dressing? 
If the person has not fallen but has balance difficulties, select appropriate questions 
to explore further. 
Box 6 - Falls history screening questions to ask during interview 
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to consultant-led falls service (secondary care).  
Any palpitations or 
angina?  
See definitions. Suggestive of cardiac disease. Ask 
about exercise-related chest pain. The first stage for 
referral is to the GP unless the pain is present at time of 
assessment (if so, urgent referral to secondary care for 
cardiac assessment.). 
A trip or stumble on a 
hazard? Explore 
circumstances. 
Ask about home environment (Chapter 11).  
Any rapid position 
change?  
May indicate postural hypotension or if head movement, 
may indicate carotid sinus hypersensitivity. Continue 
with falls assessment and consider referral to 
consultant-led falls service/ secondary care. This may 
also indicate visual dependency for stability due to 
vestibular insufficiency (with or without vertigo).  
Any visual disturbance, 
such as blurred vision? 
May indicate epileptic fit or may indicate visual problems 
associated with tripping on hazard. Continue with 
assessment also conduct vision check (Chapter 9).  
Any injuries sustained 
from the fall, bruising, 
fractures etc.? 
May indicate sudden drop and unable to protect 
themselves. Continue with falls assessment and 
consider other circumstances.  
Any facial injuries?  Similarly, indicative of sudden fall and unable to protect 
themselves.  Continue with falls assessment and 
consider referral to consultant-led falls service/ 
secondary care.  
Any tongue biting? Suggestive of epileptic fit. Ask about incontinence. 
Refer in the first instance to the GP who may refer to 
consultant-led falls service/ secondary care.  
Were they wearing a 
very tight collar around 
the time of the fall?  
Indicative of carotid sinus hypersensitivity. This will 
require referral to a consultant-led falls service.  
Have they ever been 
incontinent when/after 
falling?  
May indicate epileptic-type seizure. Enquire about 
tongue biting. Consider referral to consultant-led falls 
service.  
Do you worry about 
your balance? 
May indicate fear of falling. May benefit from balance 
retraining and reassurance.  
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CHAPTER 6 
 
Risk Assessment: 
Disturbances of gait and balance 
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Risk assessment: Disturbances of gait and balance   
6.1 Background  
Most exercise interventions to prevent falls in older adults focus on 
strength and balance training to improve gait and transfers. Gait refers to the 
manner in which someone walks and relates to walking patterns. Balance 
impairments include impairments of sitting, standing or dynamic balance. This 
relates to postural balance or the biomechanics of the musculoskeletal system 
during standing, walking, sitting and other movements. In an examination of gait 
pattern, you are looking for evidence of shuffling or feet not picking up, slower gait, 
shorter steps, or broad-based gait, postural instability and altered balance 
responses. Postural instability can be caused by altered proprioception and slowed 
processing, which can lead to increased sway whilst walking. 
6.2  Gait and balance assessment tools  
There are many published gait assessment tools: e.g. the survey of falls services 
revealed 28 different screening tests were used throughout the UK (Lamb et al, 
2007). These included the Tinetti Performance Orientated Mobility Assessment 
(POMA) balance test, the Stops Walking When Talking, Timed Up and Go Test and  
Berg Balance test. The Tinetti programme developed the POMA Balance Test, a 
task-orientated test that measures gait and balance ability (Tinetti, 1986).  This 
screening test takes 10-15 minutes to complete and incorporates aspects of sitting 
balance, standing balance, turning, gait initiation, step length and height, step 
symmetry/continuity, path, trunk sway and walking stance. A total of 16 items of 
balance and gait are assessed and scored.  
 
The NICE (NICE, 2004) Clinical Practice Statement states that for falls screening 
purposes, a simple observation of ability to stand, turn and sit is considered 
adequate as first level assessment. Therefore for the purposes of PreFIT, we ask 
that assessors use the Timed Up and Go Test. This has advantages in that it is 
simple and easy to administer in the primary care setting.     
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6.3 Treatment of gait and balance problems  
Gait retraining is the specific correction of walking technique (e.g. posture, stride 
length and cadence) and changes of pace, level and direction (Lamb et al, 2005b). 
Balance training is defined as the efficient transfer of bodyweight from one part of the 
body to another or challenges specific aspects of the balance systems e.g. vestibular 
systems. Balance retraining activities range from the re-education of basic functional 
movement patterns to a wide variety of dynamic activities that target more 
sophisticated aspects of balance. All gait and balance functional training should be 
based on an assessment of the participant’s abilities prior to starting the programme; 
tailoring of the intervention to the individuals abilities; and progression of the exercise 
programme as ability improves.  
 
6.4   Recommended PreFIT treatment: The Otago Exercise Programme  
There are various different exercise interventions to prevent falls in older adults. The 
PreFIT trial recommends the Otago Exercise Programme (OEP) for strength and 
balance retraining exercises. The OEP focuses on strengthening leg muscles, using 
ankle cuff weights for resistance, with a series of progressive balance exercises and 
a walking plan. Physiotherapists will be trained in the Otago programme and will be 
asked to deliver the intervention to trial participants referred for exercise therapy. 
 
6.5 Using the Timed Up and Go Test  
The Timed Up and Go Test was developed as a basic test for functional mobility 
(Podsiadlo & Richardson, 1991). The test includes standing up from a standard chair 
(with arms) of seat height between 40-50cm, walking a distance of three metres at a 
normal pace, turning, and then walking back to the chair to sit down. The procedure 
is timed in seconds; the original study, conducted with elderly patients with 
neurologic conditions, found that those taking longer than 30 seconds to complete 
the test were at higher risk of falls. However subsequent research with community-
dwelling, frail older adults used a TUGT test using a 14 second cut-point which was 
predictive of falls (Shumway-Cook et al, 2000). This study also used a chair with 
arms and people were told they could push off using the arms of the chair when 
standing, if they needed to.  
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Given that PreFIT is using a primary prevention approach to prevent falls in 
community-dwelling older adults, we recommend that 14 seconds be used as the 
TUGT cut-point. This is a simple test which does not require equipment or extensive 
training therefore is convenient and quick for use in clinical settings. The subject 
should wear their regular footwear and walk using their usual walking aid.  
 
For the purpose of PreFIT, we ask that during the TUGT assessment, you also 
observe for other gait-related problems e.g. stride length, foot clearance, veering to 
one side, grabbing or lunging for furniture in the room. Another factor to consider is 
whether the person is fearful of moving or turning. Fear or worry about balance is a 
risk factor for falling and should be explored during the assessment (see next few 
pages).  Appendix 11 is a laminated guide to the TUGT. 
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RISK FACTOR ASSESSMENT  b) Gait and Balance  
 
Screening for gait and balance  
 
 
 
Items required: stopwatch & measuring tape (provided) 
 
Procedure for TUGT  
- Ensure that the chair is hard-backed with arms, of seat height between 40-50cm.  
- Position the chair so that you can clearly observe the person walking. 
- Ensure that there is enough room to walk a length of 3 metres (10 feet) from the 
chair. Use the length of tape to measure the correct distance.  
- We will provide tape to indicate the correct distance.  
- Explain the procedure and demonstrate if necessary. 
- Person wears regular footwear and uses their usual walking aid.  They can use 
the arms of the chair to push off if necessary.  
- Use the stop watch provided to time the procedure.  
- Instructions to patient: “When I say go, I want you to stand up, walk to the line, 
turn and then walk back to the chair and sit down again. Walk at your normal 
pace” 
- Also observe gait pattern, look for postural sway and attempts to grab at furniture. 
- Start stopwatch on the word ‘GO’ and stop timing when they sit down again.  
 
 
 
 
 
 
 
 
 
3 metres / 10 feet 
To complete test within 14 
seconds 
 Use the Timed Up and Go Test to screen for gait and balance problems 
 Gait analysis: observe for unsteadiness, shuffling walk, uneven stride length 
Mark floor with tape  
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Scoring of test  
- Record the time taken (in seconds) on the Falls Risk Assessment Form 
(Appendix 3). 
- If participant takes longer than 14 seconds to complete, then refer to 
physiotherapy services for gait and balance retraining.  
- Consider gait pattern and if unsteady, or if attempt to use furniture for support, 
refer to physiotherapy services for gait and balance retraining. 
- Observe for postural sway during the test. Also observe ability to get up and sit 
down from a chair, ability to stand with feet together, and any problems with 
turning around. Refer to physiotherapy services for gait and balance retraining.  
- Also consider responses to falls history screening questions when deciding to 
refer for gait, balance and strength training.  
- Is the participant worried about their balance? Are they fearful of falling? Do they 
need balance retraining to improve confidence and steadiness?  
- Record if the participant is unable to perform the test – record ‘test aborted’ on 
the Falls Risk Assessment Form.  
-  
Treatment Options & Actions Required 
 
 
 
 
 
 
Refer if TUGT takes longer than 14 seconds to complete OR if participants has 
balance/gait problems that would benefit from physiotherapy training e.g. reports 
repeated tripping or stumbling during falls history interview. 
Initiate referral pathway to local physiotherapy services for Otago Exercise 
Programme. 
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Risk Assessment: 
Postural Hypotension 
 
52 
 
Risk assessment: Postural Hypotension 
 
7.1  Assessment of postural hypotension  
Postural hypotension, or orthostatic hypotension, is defined as: “a 
sustained reduction of systolic blood pressure of at least 20mmHg OR a drop in 
systolic blood pressure to below 100mmHg OR a reduction of diastolic blood 
pressure of 10mmHg within 3 minutes of standing” (Freeman et al, 2011). There are 
numerous different cut-off values for postural hypotension, however, a standard 
definition was agreed by the 1996 multi-speciality Consensus Conference sponsored 
by the American Academy of Neurology and the American Autonomic Society. This 
consensus statement was updated in 2011 (Freeman et al, 2011). The definitions 
and descriptions in the updated consensus statement have been used for the PreFIT 
study. The prevalence of postural hypotension increases with age, due to weakening 
of the postural compensatory mechanisms. Postural hypotension can occur in 
patients with neurogenerative disorders, Parkinson’s disease, pure autonomic failure 
and with disorders that affect the autonomic nerves (Freeman et al, 2011). However, 
postural hypotension can also occur as a benign, transient event, e.g. light-
headedness due to dehydration, fever, infection, over-exertion or from exercise.  
 
 
 
Box 7 - Definition of postural hypotension 
Blood pressure measurement Systolic 
     Diastolic 
A sustained reduction of systolic BP of at least 20mmHg or a drop in systolic BP to 
below 100mmHg or a reduction of diastolic BP of 10mmHg within 3 minutes of 
standing. 
Patient has postural hypotension if they are symptomatic and have any of the 
following: 
 any drop in systolic BP of at least 20mmHg OR 
 any drop in diastolic BP of at least 10mmHg on standing up. BP should be 
taken immediately on standing with a cut-off time of 3 minutes OR 
 if the systolic BP drops to below 100mmHg.   
  
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7.2   Features of postural hypotension 
Symptoms of postural hypotension include light-headedness, dizziness, pre-syncope 
or a feeling as if going to faint, and syncope (fainting). Some patients do present with 
more general complaints including: fatigue, weakness, cognitive slowing, leg 
buckling, visual disturbances e.g. blurring, headache, neck pain, breathlessness or 
chest pain (Freeman et al, 2011).  Loss of consciousness is usually of gradual onset 
but may occur suddenly.  
7.3  Syncope 
Syncope refers to a transient loss of consciousness (fainting) with spontaneous 
recovery within minutes that can be caused by loss of blood flow to the brain – 
termed ‘global cerebral hypoperfusion’. Syncope is usually a transient brief 
occurrence that resolves as soon as pulse/BP returns to normal. For instance, if BP 
drops on standing, as soon the person lies down, they then recover.  
 
Syncope may not necessarily mean serious medical disease, however it is important 
to determine the cause. Other causes of loss of consciousness may be traumatic 
(e.g. head injury) or non-traumatic e.g. epilepsy, metabolic or cardiac disease 
(Freeman et al, 2011). Epilepsy is usually a more prolonged loss of consciousness 
followed by a ‘post-ictal’ phase with a longer recovery period. Cardiac causes may 
relate to cardiac arrhythmias (slow, fast or irregular heartbeat). Cardiac pacing, or a 
pacemaker, may be required to treat bradycardia.  
7.4  Treatment of Postural hypotension  
Diuretics, anti-hypertensives and other vasodilators may contribute to a drop in blood 
pressure on standing. These drugs may include blood pressure lowering 
medications, antidepressants, in particular tricyclic agents, alpha-blockers used for 
prostate problems and selected anti-Parkinsonian drugs. Therefore if a participant is 
found to have postural hypotension, the first line of treatment is to conduct a full 
medication review (see Chapter 8). If postural hypotension continues after 
medication review and modification, then referral to a local consultant-led falls 
service may be indicated. If there signs of bradycardia with syncope, this also 
requires referral to a consultant-led falls service.   
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RISK FACTOR ASSESSMENT  c) Postural Hypotension  
 
Screening questions for postural hypotension  
 
 
 
 
 
Procedure  
- We ask that you use a manual or electronic syphgomanometer.  Ensure that 
machines have been recently checked and calibrated.  
- Explain the procedure. Ask participant to lie on couch.  
- Wait for 2 to 3 minutes before taking first reading. Record radial pulse and assess 
rate/rhythm (sinus bradycardia (<50 bpm), sinus tachycardia (>100 bpm), other).  
- Take lying BP and record.   
- Ask to stand, repeat measurement on same arm, as soon as standing and within 
3 minutes of standing. Record measurement.  
 
Scoring  
- Record radial pulse and whether regular or irregular.  
- Test is positive if drop in systolic BP of at least 20mmHG within 3 mins standing. 
- Test is positive if drop in systolic BP <100mmHg within 3mins standing. 
- Test is positive if drop in diastolic BP of at least 10mmHG within 3mins standing. 
 
 
 
Q1. Do you ever feel dizzy or lightheaded if you stand up too quickly? 
Q2. Do you ever feel dizzy or lightheaded first thing in the morning when you 
get out of bed? 
Regardless of response to Q1 or Q2, check heart rate and rhythm.  Take lying and 
standing blood pressure. 
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Treatment options / Actions Required 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Conduct full medication review and consider drugs that may cause hypotension. 
 An electrocardiogram (ECG) should be recorded for anyone with an irregular 
pulse, bradycardia or tachycardia.  
 Use an electronic ECG machine with a report.  
 If this is not available, the ECG should be interpreted by a doctor, specialist 
nurse or trained cardiac technician.  
 Use the findings from the ECG to inform your decision about treatment or 
referral for further assessment e.g. cardiology or medical referral.  
 If postural hypotension, change timing of diuretics to avoid nocturnal micturition.  
 If postural hypotension, give information leaflet (see Appendix 8) which provides 
advice about changing position slowly, not to walk when dizzy, how to tighten 
calves when getting up from a lying position etc.  
 Consider referral to consultant-led falls service if arrhythmia with syncope. 
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Risk Assessment: 
Medication Use 
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Risk assessment: Medication use  
 
8.1  Polypharmacy in older adults  
Older patients consume increasing numbers of prescription medications, over-the-
counter (OTC) medications, and other supplements. Four in five adults aged over 75 
years take at least one prescribed medicine, with 36% taking four or more 
medications (DH, 2002). Whilst medications improve disease outcomes and provide 
symptom relief, multiple medications compromise adherence and increase the 
likelihood of adverse medication effects. There is good evidence to suggest that 
patients take, on average, only half of their prescribed medications as intended 
(RPSGB, 1997). The more medications prescribed, the lower the adherence. This 
finding highlights the need for prescribers to carefully consider each medication as it 
may compromise adherence to other medications.  
 
The ageing process affects capacity to absorb and excrete medicines. In addition, 
the risk of adverse effect increases 10% with each additional medication, 
approaching 100% for persons receiving 10 or more medications (Tinetti et al, 1994). 
Many adverse reactions to medicines could be prevented – adverse drug reactions 
are implicated in 5-17% of hospital admissions (DH, 2002). It is important to balance 
disease and symptom prevention and management against the adverse effects of 
multiple medications. In the absence of an easy method for determining “net benefit 
vs. harm of a patient’s total medication regimen”, there are some general principles 
and specific steps that can lessen the likelihood of adverse effects of multiple 
medications.  
8.2  Culprit medications  
Benzodiazepines and anti-psychotic medicines are often inappropriately prescribed 
for the elderly; these can contribute significantly to risk of falls (DH, 2002).   The 
original Tinetti programme highlighted specific classes of high-risk medications, 
using the term ‘culprit’ medication for any class considered to be high risk. These 
included: anti-hypertensives, anti-arrhythmics, anti-convulsants, anti-depressants, 
anti-histamines, anti-psychotics, benzodiazepines, decongestants, diuretics, opiods 
and urinary anti-cholinergics. Some commonly prescribed medicines, including anti-
depressants, digoxin and lithium can cause problems – also non-steroidal anti-
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inflammatory drugs (NSAIDs) can cause interactions with other drugs. In 2010, the 
National Falls and Bone Health Audit in Older People specifically highlighted 
psychotropic medication and night sedation as potential causes of falling.  
8.3   Evidence for drugs associated with risk of falls  
Research studies of interventions include targeted reduction, modification and/or 
withdrawal of medications. Medications are prevalent in the treatment of morbidity in 
older adults but multiple medications do increase risk of falling. There is evidence of 
association between particular drug classes and risk of falling. In an early meta-
analysis (where findings from multiple studies are grouped), pooled results of 14 
studies indicated that taking type anti-arrhythmic drugs (to treat irregular heartbeat) 
increased the risk of falling (OR 1.22, 95% CI 1.05 to 1.42) (NICE, 2004; Leipzig et 
al, 1999). Psychotropic drugs, that affect the central nervous system, also 
increased the risk of falls, with pooled data suggesting an increased risk of 1.73 
(95% CI 1.52 to 1.97) or 73%.  
 
Other more recent systematic reviews, using improved methodology, have since 
been published since the NICE clinical practice statement. One review found that the 
main group of drugs associated with an increased risk of falling included those 
affecting the central nervous system, including the psychotropics, benzodiazepines, 
antidepressants and antipsychotics (Hartikainen et al, 2007). There was less 
evidence for antiepileptic medications and drugs that lower blood pressure – a weak 
association was found with falling. Some of the drugs used to treat high blood 
pressure are also used to treat prostate problems in males (called alpha-blockers). 
Side effects of alpha-blockers include drowsiness and postural hypotension.   
 
Another systematic review found a significant association between the use of 
sedatives/hypnotics, antidepressants and benziodiazepines and falls in older 
people (Woolcott et al, 2009).  A list of specific sedatives and antidepressant drugs is 
given in Table 2. For the purposes of PreFIT, we have broadly categorised drugs into 
2 main groups: (1) firstly the psychotropics, which predominantly affect the central 
nervous system (e.g. antidepressants, psychotropic mediations, antimanic and 
sedatives). We ask that these drugs be targeted for consideration of risk/benefit 
judgements within medication reviews.  Secondly, we ask those conducting 
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medication screening to consider other potential ‘culprit’ drugs. These include a 
broad range, but include cardiac drugs (anti-hypertensive drugs; anti-arrhythmic 
drugs; vasodilators; diuretics; vestibular suppressants, often used for 
nausea/sickness; analgesic/painkillers; anticonvulsants and anti-Parkinsonian 
drugs).  Table 3 presents examples of culprit drugs).  
8.4 Recommendations for medicines management  
The National Service Framework for Older People published guidance on the use of 
medicines for and by older people (DH, 2001). The purpose of this guidance was to: 
(a) ensure that older people gained the maximum benefit from their medication to 
maintain or increase quality and duration of life; and (b) to prevent unnecessary 
suffering from illness caused by excessive, inappropriate or inadequate consumption 
of medicine. The NSF set a review milestone that “all people over the age of 75 
should normally have their medicines review at least annually and those taking 4 or 
more medications should have a review 6-monthly.” (DH, 2001).   
 
8.5 Recommendations for medication reviews in primary care  
In 2002, the Department of Health brought medication review to the primary care 
agenda with recommendations published by the Task Force on Medicines 
Partnership and National Collaborative Medicines Management Services 
Programme (DH, 2002). This policy initiative highlighted the importance of medicines 
management with practical guidance for healthcare practitioners to develop effective 
review processes, in collaboration with patients. Medication review was defined as: 
'a structured, critical examination of a patient's medicines with the objective of 
reaching an agreement with the patient about treatment, optimising the impact of 
medicines, minimising the number of medication-related problems and reducing 
waste' (DH, 2002). Different ‘levels’ of medication review were described within this 
policy document (from Level 0 to Level 3), relating to intensity of review e.g. by level 
of assessor and whether or not in the presence of the patient.  
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Table 2 – Psychotropic Drugs that may increase risk of falling   
Also refer to Appendix 12 for full list of psychotropic-type drugs with proprietary 
names (brand names or trade names).  
BNF Section 4.1 Hypnotics and Anxiolytics   (Night sedation) 
Chloral Betaine    Loprazolam  Oxazepam  Zopiclone  
Chloral Hydrate  Lorazepam  Temazepam   
Chlordiazepoxide   Lormetazepam Zaleplon  
Diazepam    Nitrazepam  Zolpidem    
BNF Section 4.2 Antipsychotic Drugs (Pyschotropic sedation)  
Amisulpride   Haloperidol   Promazine 
Chlorpromazine  Lithium (mania) Quetiapine 
Flupentixol   Olanzipine  Risperidone 
 
BNF Section 4.3 Antidepressant Drugs 
Amitriptyline   Lofepramine  Sertraline 
Citalopram   Mirtazapine   Trazadone 
Dothiepin or Dusulepin Paroxetine  Venlafaxine 
Fluoxetine      
 
Table 3 - Other ‘Culprit’ Drugs that may increase risk of falling (Appendix 12) 
Also check other ‘culprit’ drugs from these classes:  
BNF Section 2  Cardiovascular drugs  
  2.2  Diuretics    
  2.3  Anti-arrhythmic drugs  
  2.4  Beta-adrenoceptor blocking drugs  
  2.5  Hypertension and heart failure 
  2.6  Nitrates, calcium-channel blockers & others 
BNF Section 4.9   Drugs used in Parkinsonism & related disorders 
BNF Section 7   Drugs for genito-urinary disorders   
  7.4.1   Urinary retention (alpha-blockers) 
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 8.6 Drugs that decrease the risk of fracture 
For the purposes of PreFIT, we also ask staff conducting medication reviews to 
consider whether trial participants are taking any drugs that may decrease the risk of 
fracture.  These drugs affect bone growth and are commonly prescribed to women to 
prevent or treat osteoporosis. Recent NICE guidance specified the use of 
bisphosphonate drugs as a treatment option for the primary prevention of 
osteoporotic fractures in susceptible postmenopausal women, also as treatment for 
postmenopausal women who have already had an osteoporotic fracture. Given that 
fracture is the primary outcome of PreFIT, we will record number of trial participants 
prescribed bisphosphonates during the trial period. The names of the 
bisphosphonate drugs are listed below and are also provided in the Appendix 12 as a 
laminate. 
 
Table 4 - Drugs that decrease the risk of fracture (Bisphosphonates) 
Generic Name Generic Name 
Alendronate 
Alendronic acid 
Risedronate 
Risedronate Sodium 
Etidronate  
Disodium Etidronate  
Sodium Clodronate 
Disodium Pamidronate Strontium Ranelate 
Ibandronic acid Teriparatide 
Raloxifene 
Raloxifene hydrochloride 
 
 
.  
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 Table 5 - Levels of medication review (DH, 2002) 
Level  Description  Comments  
Level 0 Unstructured, 
opportunistic review. 
Not to be undertaken 
Level 1 Prescription review   Not to be undertaken 
Level 2 Treatment review   Not to be undertaken 
Level 3 
 
 
Clinical Medication 
Review  
What: 
A face-to-face review of medicines and 
conditions conducted with the patient and 
their medical notes. Where appropriate, 
should include the carer.  
Who by:  
The GP, hospital doctor, practice nurse, 
practice support pharmacist specialist 
nurse, clinical pharmacist or community 
pharmacy working on a sessional basis. 
Must always involve the patient.  
Intervention:  
Evaluate the therapeutic efficacy of each 
drug, identify and address unmet 
therapeutic need, monitor condition 
progress, discuss aspects of medication 
with patient. 
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8.7 PreFIT requirements: medication reviews 
For the purposes of PreFIT medication reviews, we have a 2-stage protocol. We ask 
that every trial participant has an initial medication screen. This involves a face-to-
face consultation and a medication screen by the trained person conducting the 
falls assessment e.g. practice nurse or health professional from the falls team.   
 
Stage 1 – Medication screen  
Please ask the trial participant to bring a listing of their medications to the falls 
assessment. For those assessments conducted within general practice, it should be 
possible to obtain a full listing of prescriptions from the practice system. Thus ALL 
patients should have a medication screen whereby a visual review is conducted 
and all prescribed drugs are checked against the list provided in the Appendix 12. 
We ask you to record on the Falls Risk Assessment Form whether the participant is 
taking any psychotropic or culprit medications (yes/no). If the general practice or falls 
team have access to a trained community pharmacist, it is acceptable for the 
pharmacist to conduct this initial medication screen.  We also ask you to screen for 
any bisphosphonate drugs (yes/no).   
 
Stage 2 – Medication review by GP 
For trial participants currently taking psychotropic or culprit medications, they 
should then be referred to their GP or another GP in the practice, for a medication 
review. This is in line with Level 3 policy guidance, thus: 
 All PreFIT participants on psychotropic or culprit medications should have a 
comprehensive treatment review of their medicines. This should be conducted 
by the GP. The review should be undertaken face to face, wherever possible, 
with reference to medical notes.   
 Any decisions to changed medications must be made by the GP or other 
medically trained practitioner e.g. hospital consultant, if applicable.  
 Recommended factors to discuss with patients during a face-to-face Level 3 
Clinical Medication Review are given in the Risk Factor Assessment section 
(page 65).  If required, we can provide more examples of questions to ask during 
a medication review, based upon those developed by a medication advisory 
group for AgeUK (DH, 2001)  
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There are different risk assessment tools to assess medicine-related problems but 
none have been formally validated. We do not provide you with specific materials for 
medication reviews but if you would like copies of the DH (2002) Task Force 
material, please contact Julie Bruce from the PreFIT study team 
julie.bruce@warwick.ac.uk. We can provide you with links and/or template materials 
published by DoH e.g. template Patient Information Sheets, Patient Invitation Letters 
(for prescription reviews), community-based prescription review data collection 
charts etc.  
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RISK FACTOR ASSESSMENT  d) Medication Review  
 
Screening questions for medication review during the falls interview: 
  
 
 
Comp 
 
 
 
Stage 1 - Medication Screen 
Non-medically trained staff  
- Ask participant to bring a list of their current medications to the falls assessment.   
- Ask if they take any over the counter preparations.  
- Conduct a screen of all prescribed medications, ideally in the presence of their 
medical notes (not always possible).  
- Screen their drugs to identify whether on any psychotropic or culprit medications 
that may be associated with risk of falling. Use the drug listing provided in the 
Appendix 12 (laminated sheets).  
- If taking any psychotropic or culprit medications, explain to the participant that 
you would like them to have a full medication review by either their own GP or 
another GP at the surgery.  
- If possible, prepare any documentation for the GP e.g. medications, dosages, 
timing of administration.  
- Consider other risk factors and provide a copy of the falls assessment form to the 
GP or doctor, highlighting risk factors e.g. postural hypotension.  
- Liaise with PreFIT team regarding arrangements for medication review 
appointments. The process will vary across different general practices.  
- Refer to Treatment options/ Actions Required box (page 68) for advice about 
good sleep hygiene and ordering prescriptions from one pharmacy etc.   
Q1. Are you taking any medications to help you sleep? 
Q2 Are you taking any medications to help lift your mood? 
Assess all prescribed and over the counter drugs and refer patient to GP for a full 
medication review if taking any medication for sleep or mood.  Also consider other 
psychotropic and culprit medications – refer to drug list laminate at the back of the 
manual.  
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Stage 2 – Medication review by medically trained staff e.g. GP  
- Conduct a full review of all medications, with medical notes and in the presence 
of the trial participant (face-to-face consultation).  
- Conduct the medication review, considering the risk factors (if any) highlighted on 
the Falls Risk Assessment Form.  
- Consider and make adjustments to medications, where indicated. 
- Document on the falls assessment form whether any changes made (yes/no). 
The PreFIT team do not need to know specific changes, just whether or not any 
modifications were made.  
- You must sign and date any changes. 
- Arrange follow-up appointment with participant to assess progress post-review, 
as per good clinical practice.   
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Treatment options / Actions Required 
 
Other post-review actions to consider  
Possible actions arising from a medication review include:-  
 Re-examination of current diagnosis(es) and rationalize treatments according to 
clinical conditions.  
 Further investigations or information ~ this may include biochemical 
investigations or additional monitoring, e.g. creatinine levels, blood levels of 
individual drugs, such as lithium etc.  
 All changes should only be implemented by the GP or other clinician (e.g. 
hospital consultant or falls specialist) responsible for care. 
 Consider access to a pharmacist or prescribing nurse for counseling about 
medications. Note that any non-medically led initial review must be subsequently 
discussed with the GP.  
 Consider further medication review after periods of brief illness or dehydration 
episodes. 
 The patient should be informed of changes to medications and should be 
provided with a written copy of the new repeat prescription regimen.  
 Provision of medicines support items, such as medicines reminder charts or 
multi-component compliance aids.  
 Optimise non-pharmacological interventions for chronic conditions  
 Taper drugs to lower effective dose or discontinue altogether 
 Advise patients to monitor signs, symptoms and when to report 
 Advise patients to order prescriptions from one pharmacy to facilitate review 
 Advise not to add over-the-counter medications without professional review 
 Arrange follow-up appointments, if indicated, to assess impact of revision to 
medication 
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Risk Assessment: 
Vision 
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Risk assessment: Vision  
9.1 Vision and balance  
Vision makes an important contribution to balance. Control of posture, 
balance and movement involves a coordinated set of sensory processes that 
continually encodes information from visual, body awareness (proprioception), 
sensorimotor and cognitive sources (Lord et al, 2002). For example, we can 
demonstrate the impact that visual information plays in the role of maintaining 
balance by standing with our eyes closed; postural sway increases by between 20% 
and 70% (Lord et al, 2010). As we get older, our ability to judge distances, to detect 
low-contrast hazards and to process moving visual information is reduced. 
Consequently, older adults take longer to adapt to multiple sensory cues, particularly 
moving visual information, which can increase the risk of postural instability and falls. 
Impaired visual acuity (sharpness or fine detail of vision), has been identified as a 
risk factor for falls in some studies of older adults living independently in the 
community. Other studies have found no association between visual acuity and falls. 
Impairments in other systems, such as vestibular function, increase the importance 
of vision for maintaining balance during movement.  
9.2 Vision and balance  
Conditions affecting vision in the older adult include degenerative changes and loss 
of ability to accommodate to close objects – the process by which the eye can focus 
and adjust to different distances from objects. Eye disease in older adults can 
include cataracts, glaucoma, age-related macular degeneration.  Cataracts are most 
prevalent in older age groups and mostly develop in those aged over 55 years. 
Depending upon the size and location, a cataract can interfere with vision. Signs and 
symptoms include: blurred or hazy vision, reduced intensity of colours, increased 
sensitivity to glare from lights, particularly when driving at night, increased difficulty 
with nocturnal vision and changes in the eye’s refractive error. These changes can 
be very gradual but as they worsen, visual symptoms tend to increase in severity. 
Early research studies examining whether having glaucoma or cataracts increased 
the risk of falls were inconsistent: some studies demonstrated that treatment to 
correct vision led to a reduction in falls, but other studies found no reduction in falls 
nor any decrease in risk of fractures. These inconsistent findings in early studies 
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may relate to variation in methods used to assess vision e.g. visual impairment, 
visual acuity, depth perception, contrast sensitivity and others. Some studies vary in 
their accuracy for diagnosing eye disease, for example, self-report of glaucoma.  
9.3 Cataract surgery in older women  
However, there is now recent, good quality evidence from one RCT that cataract 
surgery in older women (over 70 years) does improve visual function and reduce 
recurrent falling (Harwood et al, 2005).  This trial found that women having expedited 
surgery (within one month) compared to the usual waiting list for surgery 
(approximately 13 months) had significant improvements in activity, anxiety, 
depression and a 40% reduction in risk of recurrent falls, and a reduction in risk of 
fracture.  
 
Recommended treatment of cataracts is based on the level of visual impairment they 
cause. If vision is barely affected, no treatment is required although a regular check-
up schedule is recommended.  When a cataract has progressed to the stage that it 
affects quality of life, surgery is recommended (NICE, 2007).  Modern cataract 
surgery results in rapid visual improvement and many of those treated have good 
distance vision without the need for glasses (Harwood & Conroy, 2009).  Given the 
recent evidence about benefits of cataract surgery in falls prevention, for the 
purposes of the PreFIT study, we recommend immediate referral to an optician in the 
first instance, if a cataract is suspected and this is impacting upon daily activities or 
quality of life.  
9.4 Wearing spectacles  
Other common visual problems in older adults relate to the wearing 
of glasses with an outdated prescription. This could indicate that 
older adults may not be aware of their declining vision or that they 
do not perceive the benefits of regular vision assessments (Lord et al, 2010). Cost 
and/or reduced access to eye care may also present a barrier to having regular 
vision checks although eye checks are now free for adults in the UK aged over 70 
years. Various research studies have investigated the effects of wearing single-lens 
glasses versus multifocal-lens glasses e.g. bifocal lenses. These studies have found 
that wearing bifocal glasses does impair the ability of older people to negotiate 
obstacles and can alter normal step pattern e.g. more likely to come into contact with 
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the edge of a step when stepping up, or stepping up too high. One research study 
with one year follow-up found that older adults wearing bifocal glasses were twice as 
likely to fall compared to those who wore single lens glasses (Lord et al, 2002).  
 
The NICE clinical practice guideline (2004) reviewed studies of visual interventions 
and concluded that there was insufficient evidence that single interventions targeting 
vision impairment alone prevented falls, but that referral for visual correction within a 
multifactorial intervention had a significant impact on falls reduction. Additional 
benefits from visual interventions include improvements in quality of life. Other 
reviews have highlighted that bifocal glasses can add to the risk of falls because 
near-vision lenses impair distance vision and affect depth perception, affecting the 
ability of an older person to detect environmental hazards (Lord et al, 2010). 
Therefore the wearing of multifocal/bifocal glasses should be restricted in older 
adults prone to falls.  
9.5  PreFIT requirements: Assessment of vision 
For the purposes of the PreFIT study, we ask healthcare professionals to use simple 
screening questions and an assessment of visual acuity using the Snellen chart. If 
you have any concerns about glaucoma, cataract or other possible eye disease, 
referral to an optician for detailed assessment is recommended in the first instance. 
As this is a primary prevention study, the chances of there being a previously 
undetected diplopia/double vision problem is relatively low. We ask you to 
recommend a visit to an optician if the participant wears spectacles but has had no 
eye test in the last year. 
9.6 Snellen Chart  
The Snellen Chart is used to test visual acuity. There are different types of chart but 
the classic type is that with letter of the alphabet – these are coloured black against a 
white background to provide maximum contrast.  Eye charts are configured in 
different ways, often with different number of lines of letters (e.g. 7 or 11 lines) but 
with each line being progressively smaller. The Snellen chart should be wall 
mounted and be at a sufficient distance to approximate ‘infinity’ for the lens to focus 
– this is taken as 20 feet or 6 metres. From an optical perspective, 6 metres 
approximates infinity as the difference in optical power required to focus at 6 meters 
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and infinity is minimal. The person is asked to cover one eye and read the chart from 
top to bottom, one line at a time.   
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Figure 2  – Example of a Snellen Chart 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chart  Metric 
A 
6/60 
V H 
6/36 
X U A 
6/24 
H T Y O 
6/18 
V U A X T 
6/12 
M A Y O U X 
6/9 
Y U X T H A O V 
6/6 
X O A T Y H U T 
6/5 6/5 denotes better 
than normal vision 
Where the denominator is 
greater than 6 meters = 
worse than “normal” vision. 
6/6 denotes 
“normal” vision 
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9.7  Scoring the Snellen chart  
The term 6/6 or 20/20 vision or visual acuity is used to express ‘normal’ vision or the 
clarity of vision that most can read at a distance of 6 metres (AOA, 2011).  It is 
expressed as a fraction, with the numerator or upper value referring to the distance 
in feet between the person and the chart. The denominator (6/x) refers to the size of 
the letters (this actually relates to visual angle) for which the lowest line that is read 
by an eye with no refractive error. The term is equivalent to 6/6 vision to reflect 
metric rather than imperial distance (20/20). It denotes that someone can clearly 
view or focus at 6 metres what should normally be viewed at that distance.  
 
Where the denominator (lower value) is greater than 6, this indicates poorer vision 
than normal. Where the denominator is lower than 6, this indicates better vision than 
normal. For example, someone with 6/12 vision means that the person can see at 6 
metres what a normal person sees at 12 metres, thus their vision is half as good as 
normal – or objects must be at half the normal distance for them to see them (AOA, 
2011). However, a person with 6/5 vision can see objects at 5 metres that a person 
with normal vision can only see at 6 metres, thus has better than normal vision.  
 
Visual acuity of 6/6 does not mean perfect vision; there are other aspects to vision, 
including peripheral awareness (side vision), eye coordination, depth perception, 
colour vision and ability to focus. The fraction of 6/6 does not correlate directly with 
prescriptions for spectacles because it does not specify the nature of the lens 
problem, only the overall resulting performance. For the purpose of PreFIT, the 
Snellen chart should be used as a screening tool to indicate whether or not the 
participant should be told to make an appointment to an optician.  
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RISK FACTOR ASSESSMENT  e) Vision  
 
Screening questions for vision  
 
 
Examples of exploratory questions about vision include:- 
- Any problems with reading? (suggests problem with near vision) 
- Any problems with watching TV? (suggests problem with distance vision)  
- Do you wear bifocal glasses? Refer to treatment /actions required.  
We ask you to recommend a visit to an optician if the participant wears spectacles 
but has had no eye test in the last year. 
 
Snellen Chart Test  
Position of chart 
- The Snellen chart should be wall mounted and in a well-light position. 
- The person should stand EXACTLY 6 metres from the chart.  
- The distance should be accurately calculated - use the tape measure provided in 
the manual pack.  
- Use the tape provided to mark the floor at the correct distance.  
- If the person is wearing reading glasses, these should be removed. If they wear 
glasses for driving or watching TV (distance vision), these should be worn 
during the test.  
- The person can be seated or standing.  
 
Q1. Have you had your eyes checked by an optician in the last 12 months? 
If yes, continue to Q2.  If no, conduct Snellen Test 
Q2. Has your eyesight changed or have you had any problems with your 
vision since your last appointment with the optician? 
If no, end of visual assessment. Recommend annual eye checks with optician. 
If yes, conduct Snellen Test 
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Procedure for Snellen Chart Test  
- Start with both eyes open. Cover one eye with the palm of the hand or with a 
sheet of paper.  Start with the right eye.  
- Ask them to read down the chart until they reach the smallest line of letters they 
can distinguish on the chart.  
- If they cannot complete this whilst covering the eye, an eye patch can be applied.  
- Establish the line on the chart where the person can read half or more of the 
letters correctly.  
- Repeat the test on both eyes 
Scoring  
- Record the line at which they can read half or more of the letters correctly whilst 
wearing distance vision spectacles e.g. 6/12 etc.  
- Anything less than 6/6 requires referral to optician for eye check.  
 
Treatment options / Actions Required 
- All persons aged over 70 are allowed one free eye test per year.  Encourage all 
participants to attend annual eye check. 
- If 6/6 vision or better, no further treatment required.  
- If no eye test in the last 12 months and <6/6 vision (with or without spectacles) 
ask participant to make appointment with optician for eye test. 
- If had eye test in the last 12 months but vision has deteriorated since, ask to 
make appointment with optician. 
- If you suspect eye disease or cataracts, either refer to an optician in the first 
instance for a detailed eye check. The optician can then ask GP to refer to 
ophthalmology services if required. 
- The wearing of multifocals / bifocals whilst walking outdoors should be avoided 
by older people. Advice to wear single focal glasses when walking outdoors or if 
active indoors (walking, using stairs etc).  
- Advice to take care whilst wearing new glasses.  
- If visual impairment, consider findings from the home environment assessment 
and consider referral to occupational therapy.  
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CHAPTER 10 
 
 
Risk Assessment: 
Foot problems 
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Risk assessment: Foot problems  
10.1 Foot care, footwear and risk of falls  
Core podiatry is defined as “the assessment, diagnosis and treatment of 
common and more complex lower limb pathologies associated with the toenails, soft 
tissues and the musculoskeletal system with the purpose of sustaining or improving 
foot health” (Farndon et al, 2009). Up to 1 in 3 older people suffer from foot 
problems, such as foot pain, toe deformity, weakness or restricted range of motion 
(Spink et al, 2011; Menz et al, 2010). These problems are common reasons for 
attending primary care services. Other UK foot surveys suggest that the main foot 
conditions affecting older people requiring core podiatry include nail problems, corns, 
calluses and toe deformities (Farndon et al, 2009).  
 
Foot problems are risk factors for falling: studies of older people with a history of 
multiple falls suggest that they are more likely to have foot impairment, such as pain 
or deformity (Spink et al, 2011). Other studies have found that poor footwear or the 
presence of a corn or bunion were significant independent risk factors for falls 
(Dolinis et al, 1997).  Evidence regarding inappropriate footwear and falls comes 
from both research studies in the laboratory setting but also from population 
(epidemiological) studies investigating risk of falls in older adults. Shoes with an 
elevated heel of even medium height (4.5cm) have been found to significantly 
increase postural sway and impair overall balance performance (Menant et al, 
2008b). Other features of ‘inappropriate’ footwear include shoes without laces, straps 
or buckles, reduced sole contact area, soft-soled shoes and those without heel 
support (Menant et al, 2008b; Spink et al, 2011). A review of the contribution of 
footwear to risk of falls concluded that walking barefoot or in socks increased the risk 
of falls indoors, although most evidence comes from studies of older adults resident 
in care homes (Menant et al, 2008a). Shoes with a higher heel cuff or collar (refer to 
Figure 3) provide mechanical ankle support and can help prevent inversion. 
 
10.2  National guidance for foot care / footwear in older adults  
The efficacy of including foot/footwear/podiatry assessments within multifactorial falls 
programmes was reviewed by NICE and within systematic reviews of falls prevention 
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(Gillespie et al, 2003; Gillespie et al, 2009; Gates et al, 2008; NICE, 2004). These 
reviews found there was no overall, conclusive evidence of benefit of a stand-alone a 
foot assessment and treatment intervention in preventing falls. Although the NICE 
Clinical Practice Statement and AGS/BGS policies agree that examination of the feet 
and simple advice about footwear should be included within any MFFP programme, 
these guidelines did not specify which assessment or intervention activities should 
be undertaken (NICE, 2004). 
One trial published since the policy guidance found that a multifaceted podiatry 
intervention significantly reduced the rate of falls in community dwelling older adults 
with disabling foot pain compared to routine podiatry care (Spink et al, 2011). The 
intervention comprised a foot and ankle exercise programme, a prefabricated 
supportive orthoses (moulded foam insert), advice on footwear, subsidised footwear 
and general falls education advice booklet.  Rate of falls and fractures were lower in 
the intervention group and strength, balance, range of motion were also significantly 
improved compared to those receiving usual podiatry care (Spink et al, 2011). 
Authors concluded that these components were inexpensive and relatively easy to 
implement, suggesting they could be incorporated into routine podiatry care.  
10.3   PreFIT Study: assessment of feet and footwear  
For the purpose of PreFIT we ask that you conduct a visual examination of feet to 
check for obvious bunions, hammertoes, calluses or nails that may cause pain or 
gait disturbances. If you are concerned about numbness or foot positioning, you 
should conduct a simple check of propriception. Access to NHS community podiatry 
services does vary from region to region; some NHS services provide free podiatry 
or chiropody to diabetic patients. 
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i. Procedure for conducting tests of proprioception and numbness 
Test for proprioception  
 The person should be seated on a chair with their shoes and socks removed.  
 Explain the procedure – you are going to move their big toe in different 
directions and want them to specify whether the toe is being moved up/down 
(or backwards/forwards). This will be repeated on both feet.  
 Ask them to close their eyes. 
 Hold the right foot and grasp the toe at the sides with your fingers.  
 Move the big toe by 2mm in different directions and ask the person to report 
the direction of movement (either up, down, backwards or forwards).  
 You can do this up to 3 times on the toe (if person cannot follow first attempt) 
 Incorrect responses may indicate neurological illness.   
 
Test for numbness/Sensation check (conduct if you suspect foot numbness) 
 Person can be seated or lying, but with socks and shoes removed 
 Explain procedure – you will need a cotton wool ball 
 Rub the cotton wool ball lightly across the sternum as a reference guide (ask 
if they can feel the sensation) 
 Ask them to close their eyes 
 Start with the R foot, lightly brush cotton wool across the toes 
 Ask if they can feel the sensation. Ask whether feels the same or different to 
the sensation on the sternum. 
 Repeat on L foot. Ask whether any difference between L or R foot.  
 
10.4  PreFIT requirement: provide advice about feet and footwear  
Assessment of footwear will be largely based upon what the study participant is 
wearing at the time of interview, however we ask that you assess footwear and 
provide simple advice about what is appropriate footwear. Footwear can cause foot 
problems therefore by helping patients to recognise and make sensible choices 
about footwear can help prevent the development of new problems or any 
deterioration of existing foot conditions. Simple footwear advice includes: wearing 
cotton socks and leather shoes; ensuring that the shoe is properly fitted and wide 
enough to prevent pressure on the toes; and that the shoe has features 
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demonstrated in Figure 3. Preferably, shoes should be worn both indoors and 
outdoors but if slippers are worn indoors, they should adhere to the same criteria - 
thus have good heel support, have a non-slip sole and not be worn or frayed.   
 
Advice about care of the feet is also provided within the AgeUK leaflet which is 
provided to all study participants referred for MFFP. If a participant also requires 
onward referral to exercise therapy, assessment foot positioning, gait and balance 
will be undertaken within the Otago Exercise Programme.  
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Features of shoes recommended for older people:  
 Shoe has a supportive heel-collar or ‘closed cup’; 
 Low heel height of less than 1.5” height (2cm); 
 Heel is slightly beveled; 
 Shoe is fastened using laces, straps or buckles for support; 
 A thin firm midsole to allow sensory input; 
 Slip resistant sole 
 A wide fitting to allow toe movement.  
 
 
 
 
Figure 3 - Recommended shoe features for older people 
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RISK FACTOR ASSESSMENT  f) Foot Care and Footwear  
 
Screening questions for foot care  
 
Assessment  
- Ask to remove shoes and socks. Check for marks on the skin after removal of 
socks and shoes.  
- Conduct visual inspection – look for bunions, corns, calluses, hammertoes, in-
growing or overgrown toenails.  
- Check for foot ulcers and assess whether any foot numbness.  
- Only if you suspect numbness, then conduct the simple proprioception test. 
- Check type and condition of footwear.  
- Consider gait from the TUGT screening test and whether gait indicative of 
underlying disease e.g. Parkinson’s, stroke or hip/knee osteoarthritis.   
 
Recommended advice  
- Wear cotton socks and leather shoes that ‘breathe’.  
- Check shoes for stones before wearing.  
- Tip of shoe should extend 1” beyond great toe and should be wide enough for 
metatarsal heads without pressure areas – refer to Figure 3.  
- Wear shoes with good arch support, closed heel and heel height less than 1.5” 
(3.8cm).  
- Wear shoes with soles that are at least as wide as the sole of the foot, with non-
slippery surface. 
- Wear shoes that are not too thick as to decrease sensory input or create a 
hazard for tripping.  
Q1. Do you have any problems with your feet? 
Q2. Any pain in your feet? 
Q3. Any numbness in your feet? 
Q4. Do you have diabetes? 
Q5. Do you attend chiropody/podiatry services? 
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- Preferably, shoes should be worn both indoors and outdoors but if slippers are 
worn indoors, they should adhere to the above criteria - thus have heel support 
and not be worn or frayed.  
 
Treatment options / Actions Required 
 Refer to local podiatry/chiropody services if available. 
 Consider referral to physiotherapy services for balance retraining if you are 
concerned about gait style or foot placement. 
 Provide advice as above and give AgeUK leaflet which contains foot care 
advice. 
 Consider referral to relevant secondary care services if indicated e.g. diabetic 
services. 
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CHAPTER 11  
 
 
 
 
 
 
 
 
Risk Assessment: 
Home Environment 
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Risk assessment: the home environment  
11.1 Environmental hazards 
Environmental hazards in the home are often cited by policy makers 
and older people as significant risk factors for falls in older adults living in the 
community. However, it is difficult to single out the most effective intervention within 
any home environment assessment/modification programme. The 2004 NICE 
guidance reports on different studies of home hazard modification and safety 
interventions. There is one good quality trial demonstrating that home hazard 
assessment with a supervised modification programme is effective in reducing falls 
in those discharged from hospital. However, the association with domestic hazards 
and falling has been generally controversial – in those without a history of falls in the 
previous year, there is no evidence of effectiveness (NICE, 2004). Of the trials of 
home hazard modification in previous fallers (secondary prevention), six trials have 
reported effectiveness, although this observed effect was thought to be unlikely to be 
from the home hazard interventions alone, because of the reductions in falls which 
occurred outside of the home (Gates et al, 2008; NICE, 2004). The evidence 
suggests that home hazard removal and advice about functional activities is most 
effective in reducing falls in individuals with visual impairment (Gates et al, 2008).  
 
Despite the controversy, what is important is that benefit is only achieved if home 
hazard assessment is carried out through a functional assessment and is followed-
up with specific intervention – although this applies to all components of multifactorial 
assessment and intervention programmes, not just home hazard assessments. 
There is no evidence to support merely screening for home hazards without direct 
observation of the individual carrying out functional tasks within their home 
environment (Clemson et al, 2008; Pighills et al, 2011). Equally, the evidence 
suggests that to enhance adherence, older people have to acknowledge that the 
identified hazard is a potential falls risk and own the solution through a joint problem 
solving process (Clemson et al, 1999). 
11.2 National guidance  
The guidance from NICE acknowledges that a suitably trained member of the health 
care team can conduct home hazard assessments - this may include a clinician, 
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occupational therapist, nurse, physiotherapist, social work, or other trained assessor.  
The AGS/BGS guidance also states that environmental assessment of home safety 
should be conducted and that interventions should include the adaptation or 
modification of the home environment. The purpose of is to mitigate identified 
hazards in the home, evaluate and intervene to promote the safe performance of 
daily activities.  
11.3 PreFIT requirements: assessment and treatment  
For the purposes of PreFIT, it is not a prerequisite that a home assessment is 
conducted for every participant. However, if you have concerns about the safety of 
performing activities at home, either from the detailed falls history or the presence of 
potentially hazardous features, we do ask that you refer to relevant services for a 
home assessment, for example, occupational therapist or social services. An 
example would include someone with a history of repeated stumbles during a 
particular activity e.g. rising from the bed or toilet, (or climbing stairs) or place where 
there may be obstacles on the floor.  
 
In addition to onward referral of selected participants, we ask that you provide ALL 
participants with the AgeUK advice leaflet (Appendix 1) and a PreFIT study Tip 
Sheet “Staying Safe at Home” (Appendix 7). These leaflets provide simple checklists 
for checking the home environment.  
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RISK FACTOR ASSESSMENT  g) Environmental Hazards  
 
Screening questions for environmental hazards  
 
Assessment  
- Consider responses from falls history interview e.g. whether the participant 
reported tripping indoors or outdoors. Consider responses to screening questions 
about stairs. 
 
Recommended advice  
• Advise to check for any hazards at home e.g. remove anything that will impede or 
obstruct their path; uneven walking surfaces, such as cords, area rugs, clutter, or 
furniture etc. 
• Install aid to raise the toilet seat, if needed. 
• Check on outdoor walking paths, ensure these are well-lit both day and night. 
• Install blinds or curtains that easily accessed and adjusted to avoid glare – and let 
in light if darkened room.  
• Advise to move commonly used objects so they are within reach.  
• Avoid reaching overhead or bending over and lifting from floor.  
• Consider installation of handrails to stairs or hallway if necessary.  
• Advice not to obstruct view of feet and not to carry bulky or heavy items up or 
down stairs  
• Suggest asking for help when changing ceiling bulbs, curtains, smoke detector 
batteries etc. 
• Advise to put on lights when rising to the bathroom in the middle of the night.  
• Advise to use heating in winter months, particularly for those living alone.  
Q1. Do you use the furniture to support you when walking around the house? 
Q2. Do you have difficulty getting out of a chair or rising up from the toilet? 
Q3. Do you have stairs at home or steps up to your front door? 
Q4. How do you cope with going up and down stairs? 
Q5. Do you use a walking aid? 
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Treatment options / Actions Required 
 Consider referral to occupational therapy services, if available, for 
assessment of home environment. 
 Give AgeUK leaflet which also contains home safety advice. 
 Give PreFIT Home Safety Tip Sheet which contains home safety advice 
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CASE STUDY 1  
General practices have agreed to participate in the PreFIT study and have been 
randomised to deliver MFFP. Staff at these practices have been trained by the 
PreFIT study team in falls assessment.  
 
Assessment  
A 73 year old lady is a trial participant. She returns her screening survey form and is 
considered at risk of falling although has not previously attended any falls service. 
She is invited for MFFP assessment; she is initially reviewed by the practice nurse 
and then the GP. She is worried that she is a bit unsteady and has had a few near 
misses but no actual falls. There is no postural drop in her BP, her sole medication is 
a low dose non-steroidal anti-inflammatory (NSAID) for shoulder pain, but is 
otherwise healthy – although her shoulder only limits her slightly, she still walks her 
dog ½ mile every day.  
Her vision is normal and she had an eye test 9 months ago. Her feet show no major 
issues with normal proprioception. On the TUGT test, she does complete it within 14 
seconds but has a bit of sway. She lives independently with no services and doesn’t 
use a stick or walking aid. 
 
Intervention 
 Referral to physiotherapy for gait and balance retraining (Otago Exercise 
Programme). 
This example shows somebody who is starting to develop a risk for falls but has no 
major problems. We don’t know if early intervention helps here but the PreFIT study 
will help answer this type of “primary” prevention issue. 
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CASE STUDY 2  
 
Assessment  
An 82 year old man is a trial participant. The gentleman has had 3 falls in the last 
year, two when walking along a pavement, stepping on or off kerbs, and one coming 
down a short flight of stairs. He has not attended any services for these falls. He has 
hypertension and prostatism (gets up to pass urine twice during the night). He lives 
with his wife and she has early dementia. He does the shopping and cooking, and he 
can walk around the shops unaided.  
 
Drugs: on bendroflumethiazide (BP), amlodipine (BP) & doxazosin (alpha blocker for 
prostate and BP) plus aspirin. He has started using temazepam more frequently to 
help him sleep at night. On examination, he wears glasses (bifocals) and has 
recently changed from separate reading and distance glasses although there was no 
deterioration in his vision when the optician checked a few months ago apart from 
noting a very early cataract. His BP is lying 155/87 & standing 134/84 
(asymptomatic). His feet are in good shape. His TUGT was 18 seconds (so mildly 
increased) and he was also rather unsteady on turning.  
 
Intervention  
 Referral to physiotherapy services for gait and balance retraining.  
 He is also given advice to go back to the optician for separate glasses (?cause of 
fall on steps).  
 His medication review leads to a change in his alpha blocker to an alternative 
drug for his prostate that doesn’t cause postural hypotension. 
 His poor sleep is due to worries about his wife’s dementia therefore his GP 
organises a separate review to look at how he might be better supported in this 
role, including linking in with a local carers’ support group. His use of temazepam 
is discussed and the patient and GP agree to try weaning it and then not taking it 
for 6 months. 
 Home hazard assessment to address safety on the stairs, night lighting etc  
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Thus ‘treatment’ is: (a) physiotherapy; (b) optician; (c) medication modification with 
review within 3 to 6 months; (d) home environmental assessment; and (e) advice 
and support (social).  
 
This example shows a patient who is starting to fall but who has some clearly 
modifiable risk factors that can be managed in primary care, alongside simple factors 
such as changing spectacles. Minimising sedatives can reduce falls by 30%. 
Relatively straightforward medication reviews can sometimes solve postural 
hypotension. This is the sort of patient that the Pre-Fit study might show as 
benefiting from physiotherapy and from a GP-led medication review. 
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CASE STUDY 3  
 
Assessment  
A 77 year woman consents to Pre-Fit. She has had multiple unwitnessed falls, 
including one with a long lie on the floor - the patient has a number of bruises 
including on the face. She never remembers actually falling. The patient has treated 
angina, but still gets chest pain on hills and gets palpitations once a fortnight or so.  
Her TUGT is normal. BP lying is 175/90 and standing 120/68 (postural hypotension). 
Her heart rate is 51/minute (bradycardia). Her eyesight is normal on the Snellen 
chart whilst wearing distance spectacles and her feet are in good condition. She lives 
alone, gets to the shops by taxi and is otherwise independent. 
 
Drugs: She is on multiple medications including perindopril, isosorbide mononitrate, 
bendroflumethiazide, doaxazosin and amlodipine plus atenolol.  
 
This patient has red flags for syncope - multiple unwitnessed falls without 
recollection of falling plus facial bruises. She has difficult postural hypotension as 
may still need to take cardiac medication to prevent angina. The medication review 
could again be done in primary care but with possible syncope and palpitations, this 
patient would probably benefit from a comprehensive falls/syncope service 
assessment. Falls here may be multi-factorial. Exercise in a patient with symptomatic 
angina may need careful individual planning.  
 
 
Intervention  
This patient is eligible for referral to a consultant-led falls service, either to local 
community falls service (as long as consultant-led) or secondary care referral.  
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CHAPTER 12 
 
 
 
 
 
 
MFFP Assessment (who, where and when) 
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12. PROCESS FOR REFERRAL AND ASSESSMENT  
12.1 Process for referral for MFFP assessment  
General Practice staff are responsible for conducting the balance survey to identify 
trial participants with a history of falling and/or poor balance.  This procedure is 
described within the practice manual. These balance forms are then coded by the 
PreFIT office and referral forms are generated. Based upon responses to the 
balance survey, trial participants considered at high or intermediate risk of falling are 
eligible for MFFP assessment. These include multiple fallers (high risk), single fallers 
and those with balance problems (intermediate risk).  
 
As the trial is pragmatic and delivered within ‘usual’ clinical care, there are different 
models for referral and assessment. The 2 most common models for assessment 
are: (a) MFFP assessment by practice nurses or other trained staff within the general 
practice; (b) MFFP assessment by falls service team.  
 
The PreFIT office will generate the referral forms; these forms give name, contact 
details and PreFIT ID number for each participant that requires a falls assessment. 
These forms also clearly state that the trial participant requires MFFP assessment as 
per the PreFIT intervention manual. The practice or falls service must then arrange a 
suitable time and venue for initial assessment. 
 
a) MFFP Assessment by General Practice Staff  
Where the general practice has responsibility for conducting falls assessment, they 
should arrange an appointment for each trial participant. Based upon feedback from 
practices taking part in the pilot phase of the study, we found that the optimal model 
was where practice staff established set up dedicated falls clinics e.g. morning or 
afternoon clinic to assess trial participants. The PreFIT team will liaise with individual 
practices to discuss processes for monitoring each participant.  
 
b) MFFP Assessment by Falls Service Team  
The falls service should arrange a suitable time and venue for assessment. Some 
falls services inform patients by telephone with a follow-up confirmation letter of 
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time/date of appointment. The PreFIT team will liaise with the falls team to discuss 
optimal processes. We can provide template documentation if necessary e.g. 
invitation letters. In the Appendix 9, there is a document providing advice for making 
the first telephone call to study participants.  
  
12.2  Who conducts the MFFP assessment?  
The MFFP assessment must only be conducted by staff (from general practice or 
local falls service) that have completed training in the PreFIT intervention. Therefore 
all personnel likely to be involved in delivery of the trial intervention must attend 
training sessions provided by the PreFIT study team. The local research nurse will 
liaise with staff to arrange training.  We also provide short training to general 
practitioners responsible for conducting medication reviews.  
 
12.3 Where should the MFFP assessment be conducted?  
The MFFP assessment can be conducted at the general practice, or any other 
suitable location. Assessments can be undertaken in the ‘usual’ location for 
comprehensive falls assessment (e.g. community clinic or falls clinic located within 
secondary care). Ideally, the location of assessment should be conducted near to the 
general practice to facilitate the medication reviews. For some areas, falls 
assessments have been conducted by the falls team within the general practice. As 
this is a pragmatic clinical trial, procedures will vary from region to region.  
 
12.4 How long is the MFFP assessment?  
The MFFP assessment can be conducted as soon as staff complete PreFIT MFFP 
training and when trial participants have been identified e.g. balance screening 
survey completed and referral forms generated. We ask that the assessments be 
completed within a timely manner (e.g. ideally within 6-8 weeks of receipt of 
referrals).  As described above, the general practice or local falls service should 
make an appointment for each trial participant.  We recommend that the appointment 
should be for 45 to 50 minutes.  This is based upon previous falls assessment 
literature whereby the average falls assessment lasted between 30 and 45 minutes.  
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For patients who have fallen multiple times, this appointment may take up to 50 
minutes e.g. to explore causes and consequences of recent falls.  
Assessment appointments can be booked as joint appointments.  For example, the 
trained practice nurse may assess some risk factors e.g. conduct the falls history 
interview, conduct the Timed Up and Go test, consider gait and balance during the 
test, take lying and standing BP, assess condition of feet, conduct the footwear 
check and ask about home environment and circumstances. The practice nurse (or 
other health care staff) will also be trained in how to screen for psychotropic and 
culprit medications.  
 
The GP must review all initial tests conducted by the practice nurse and should 
consider red flags for falls and/or poor balance. The GP must also complete the 
medication review and must review and sign off any recommended treatment 
pathways that have been identified by the practice nurse.  The time for GP 
assessment may take 10-15 minutes.  
 
12.5 Can we assess other factors during the MFFP assessment?  
For all trial participants, we ask that you adhere closely to the PreFIT study manual 
and only assess the risk factors listed within the manual.  It is essential that staff 
responsible for delivery of the trial intervention adhere to the recommended PreFIT 
assessment and treatment pathways in order to ‘standardise’ the intervention across 
different centres. For all other non-trial patients attending falls services, you can 
conduct assessments in the usual manner according to your local pathways.  
 
12.6 Tracking trial participants  
It is important for the PreFIT study team to track throughput of trial participants to 
avoid overburdening of local services. We aim to work closely with general practices 
and local falls services to stagger participant throughput wherever possible. The 
local research nurse or PreFIT office will liaise with practices and services on a 
regular basis to monitor throughput.  We have developed template Microsoft Excel 
spreadsheets which list anonymised IDs of each trial participant and ask that these 
be returned to the main office on a monthly basis.  If you have any queries, please 
feel free to contact the PreFIT office at any time. 
101 
 
12.7 Trial Reporting Procedures  
There is one document to be completed for each trial participant – the Falls Risk 
Assessment Form. Please keep a copy of the form at the practice or with the falls 
team and return to the original to the PreFIT office (or store in the PreFIT “Red Box 
file”).   
 
 
Form 1: Falls Risk Assessment Form 
The Falls Risk Assessment Form should be completed during the 
assessment interview with the study participant.  
 Each risk factor should be assessed according to the guidance within this 
manual. This form lists each of the main risk factors and allows you to record 
details of onward referrals and treatment decisions.  
 Different staff members may be involved in the assessment process therefore the 
form details of who conducted the assessment (e.g. designation) must be 
provided.    
 The medication review section must be signed by the GP who conducted the full 
medication review. 
 Please take a copy of the completed form to be stored in the patient’s medical 
records. Please return the original MFFP form to the PreFIT office (or red box).  
 The local PreFIT research nurse of study office may get back in touch to discuss 
any treatment actions/outcomes relating to onward referral.  
 If the participant has been assessed and no treatment or onward referral is 
required, the assessor should complete the Falls Risk Assessment Form and 
return to the Red Box File held in the practice).  
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Figure 4 - Participant pathway for MFFP assessment and treatment 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Trial participant entered into study; 
screened by GP & considered at 
risk of falling 
REFERRAL  
PreFIT office generates 
referral forms  
Referral form gives name, 
PreFIT ID, address & contact 
details for those who need to be 
invited for a falls assessment 
Refer to MFFP service  
Either: 
(a) GP led service 
(b) Local community falls service 
(c) Other service model  
Within 3 months  
Follow-up any onward referrals to 
ensure treatment initiated, ongoing or 
completed.  
If satisfied that treatment has been 
initiated or completed, then MFFP 
intervention is complete.  
 
Falls Assessment  
Check EVERY risk factor according to 
PreFIT manual.  
Initiate treatment pathways according 
to manual. Screen medications & 
check for psychotropic/culprit meds. 
 
DISCHARGE 
Patient ‘discharged’ from PreFIT 
MFFP service. Return fully 
completed Falls Risk Assessment 
Form and return to study office.  
Falls Service or practice contacts 
participant to arrange appointment 
for falls assessment 
Refer to GP if require medication 
review. Arrange other referral 
appointments. 
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CHAPTER 12.  KEY POINTS  
 
 Referral forms are generated by the PreFIT office and given to the 
falls service or general practice responsible for assessments. 
 
 
 There is one MFFP document to be completed and returned to the 
study office: the Falls Risk Assessment Form.  
 
 The Falls Risk Assessment Form is completed during the 
assessment.   
 
 Screen for EVERY risk factor on EVERY participant. Also screen 
medications to identify any psychotropic and culprit drugs. If taking 
psychotropic or culprit drugs, refer to GP for full medication review. 
  
 Record whether and any onward referrals made e.g. referral to 
physiotherapist or hospital consultant etc. 
 
 Store forms in PreFIT box file until referrals /GP appointments have 
been made.  
 
 Once all sections of the form have been completed and signed, take 
a copy for your own service or GP practice and then return the 
original form to the PreFIT study office. 
  
 The study office will liaise with you regarding monthly monitoring to 
keep track of trial patients e.g. those assessed / those waiting to be 
assessed.  
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CHAPTER 13 
 
 
 
 
 
 
 
Adverse Event Reporting 
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13. REPORTING ADVERSE EVENTS  
 
13.1 Introduction  
This section defines the different types of adverse events and the process for 
reporting these events to the study team. The accurate and timely reporting of 
adverse events is a requirement of Good Clinical Practice. The Chief Investigator of 
the PreFIT study (Professor Sallie Lamb) is responsible for the reporting of relevant 
adverse events and for the safety reporting of participants for the study Sponsor at 
regular time intervals. Reports are submitted to the funder, to the Data Monitoring 
Committee, (who overview trial safety), to NHS Health Technology Assessment 
panel and to the Ethics Committee.  
 
All staff that have contact with trial participants have a responsibility to note any 
adverse events mentioned by participants and communicate these to the Chief 
Investigator via the trial team. This includes serious adverse events and other 
reportable events. The incidence of serious events should be monitored during 
intervention sessions. Time to first fracture will be monitored as the main safety 
outcome measurement.   
 
Each participant will have had a clinical assessment done – this will provide 
information on relevant co-morbidities, procedures etc. The PreFIT study population 
are all aged over 70 years therefore we do not consider the normal ups and downs 
of chronic diseases of old age to be adverse events – i.e. osteoarthritis etc. It is 
expected that participants will experience some uncomfortable effects of participation 
in the intervention – for example muscle or joint soreness in response to exercise, 
feeling unwell or anxious after withdrawal of medication. These and similar effects 
are entirely to be anticipated, and provided they are short lived or dealt with through 
clinical management should not be reported as adverse events. 
 
Events are only to be reported if they occur during the following time periods: 
 During contact time with any healthcare professional delivering the 
intervention; 
 During an intervention session (e.g during MFFP assessment); 
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 If receiving an exercise intervention (e.g. if referred for exercise), an event 
occurs whilst undertaking study exercises prescribed by the study 
physiotherapist – either supervised or unsupervised.  
  
13.2 Events that DO require reporting  
If a study participant is referred for MFFP, healthcare professionals will be required 
to report serious adverse events that have, in their opinion occurred directly as a 
consequence of the treatment and were unexpected, unintended or 
unanticipated. Thus any event occurring as a direct consequence of the treatment 
and resulting in death, threat to life, hospitalisation, disability or incapacity should be 
reported. 
Events to be reported should only include those that require professional medical 
attention, including, but not restricted to: 
 Injurious falls resulting in fracture or serious injury  
 Myocardial Infarction 
 Uncontrolled Angina 
 Cerebral vascular accident 
 
Musculoskeletal injuries requiring professional medical attention including 
serious sprains, joint dislocation, falls or other injuries occurring as a direct 
consequence of the intervention (i.e. whilst participating in the intervention in real-
time) should also be reported.    
 
You should complete an Adverse Event Notification (Appendix 5) immediately after 
becoming aware of any suspected adverse event. The Trial Coordinator (Emma 
Withers) should be informed of all such events as soon as possible, and when 
serious always within one working day. (Box 8).   
 
13.3 Other Reportable Events  
Where attribution to the intervention or “expectedness” cannot be confirmed, the 
event should be reported to the Trial Coordinator (Emma Withers). These incidents 
will be reviewed by the Chief Investigator. If you are unsure about a particular event, 
please contact the study team for advice.  
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13.4 Role and responsibility of healthcare professionals delivering the MFFP 
intervention   
The healthcare professional primarily responsible for delivery of the intervention 
should complete an Adverse Event Notification Form immediately after they become 
aware of any reportable adverse event. The Trial Coordinator should be informed of 
all such events as soon as possible, and when serious, always within one 
working day.    
  
Box 8 - Adverse Event Notification form (refer to Appendix 5). 
 Enter the participant’s identification number onto the front sheet  
 Section 1 – participant details: enter the participants initials and date of birth  
 Section 2 – Reason for reporting: indicate in this section if the event is a death, life 
threatening event, hospitalisation, disability/incapacity or other medically significant 
event.  If it is another medically significant event please include details i.e.(but not 
restricted to) falls, myocardial infarction, uncontrolled angina,  cerebral vascular 
accident, musculoskeletal injuries requiring medical attention—serious sprains, joint 
dislocation etc.  
 Section 3 – Case Description: enter the date that you deem the event became 
serious, details of any relevant medical history and details of the event – continue 
these descriptions on a separate sheet if necessary (please ensure that you include 
the participants ID number, section number, your signature and the date of 
completion on the additional sheet) 
 Section 4 – Trial Treatment: Indicate if you feel that the event is related to the trial 
and provide details of why you feel the event is related i.e. took place during an 
exercise class, indicate if you have discharged the participant from any further trial 
related procedures as a result of the event i.e. completion of any bending exercises 
and if the participant has been discharged from intervention activities the date of 
discharge 
 Section 5 – Your details: please complete in block capitals 
Then please fax the form to the Warwick Clinical Trials Unit on  
024 7615 0549. 
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13.5 Reporting a Death  
If the therapy team are informed about the death of a trial participant during the 
study period please let us know as soon as possible in order to avoid any 
possible distress to the bereaved family caused by inappropriate follow up.  
Please inform the local research nurse immediately. The local research nurse has 
copies of the “Event Notification Form” (Appendix 6). In the event of a death, the 
local research nurse will complete this form and fax it immediately to the PreFIT 
study team. 
 
13.6 Withdrawal from study  
If a participant would like to withdraw from the study, please inform the local 
research nurse immediately. The local research nurse will complete the Event 
Notification Form and will fax this to the PreFIT study team.   
 
13.7 Complaints procedure  
In the unlikely event that a participant or potential participant makes a complaint 
about any aspect of the trial, please inform the local research nurse.  The local 
research nurse will complete the Event Notification Form and will fax this to the 
PreFIT study team. It is our experience that complaints are rare from trial 
participants. If a complaint does occur it can usually be dealt with most effectively if 
the scientist in charge of the trial contacts the participant as soon as possible to 
discuss the problem.  
 
13.8  Events that do NOT require reporting  
We expect that participants might experience some uncomfortable effects of taking 
part in the intervention – for example, feeling unwell or anxious after withdrawal of 
medication. These effects are entirely to be anticipated, and provided they are short 
lived or dealt with through clinical management should not be reported as adverse 
events.  
 
If you have any queries or concerns about adverse event reporting, please contact 
the study team for advice at prefit@warwick.ac.uk.  
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